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Undiagnosed HIV among men who have sex with men (MSM) remains a significant public health 
challenge in the UK. Higher rates of recent and repeat HIV testing are necessary to ensure recent 
falls in HIV incidence among MSM in parts of England and Wales are fully reproduced nationally. HIV 
self-testing (HIVST) is the latest in a long line of HIV testing interventions, which has been developed 
to reduce barriers to testing for those at risk of acquiring the virus. An HIV Self-testing Public Health 
Intervention (SELPHI) is the first randomised controlled trial (RCT) delivering free HIVST kits to MSM 
in Europe.  SELPHI has two interventions and aims to assess whether HIVST can increase diagnosis of 
prevalent HIV infections (intervention A) and reduce the time between infection and diagnosis for 
those at on-going risk of new HIV infections (intervention B). Social sciences have been at the heart 
of SELPHI, contributing to formative, implementation and evaluation research.  
This thesis seeks to develop an understanding of the potential contribution of HIVST to the well-
being of MSM in England & Wales. It contributes significantly to the academy by developing a 
comprehensive evidence base enabling policy makers and service providers to optimise HIVST 
service delivery.  
Methods 
This work is conceptually grounded in implementation science and uses the Behaviour Change 
Wheel (BCW), which includes the COM-B model of behaviour change to provide a framework for 
intervention development and to understand participant outcomes. A pragmatic, multi-method 
approach has been taken whereby the optimal data collection methods have been carefully selected 
based on their suitability to answer the research questions.  
Results 
This thesis includes three studies presented over five published papers. The first is a formative study 
(contributing to papers 1 and 2) of qualitative focus group discussions with MSM which produces 
new understandings of the diversity of their values and preferences with regard to HIVST. This study 
also interrogates narrative understandings of the potential use of the technology, demonstrating 
HIVST use may be limited to when MSM do not perceive significant risk, except in the context of 
significant barriers to service access. The second study (contributing to paper 3) is a mixed methods 
interrogation of the implementation pilot, demonstrating high feasibility and acceptability of an 
HIVST intervention delivered to MSM through the SELPHI study. The final study (contributing to 
papers 4 and 5) is an evaluative analysis of qualitative in-depth interviews with individuals who have 
undergone HIVST, showing high acceptability and varying intervention performance across groups. 
The utility of COM-B as a model for understanding behaviour change in relation to HIVST is examined 




Online delivery of HIVST to MSM is feasible and acceptable; contexts of use and intervention 
performance will vary across groups. A number of intervention adaptations can be made to increase 
acceptability and the potential reach of HIVST interventions. The absence of a robust concept of 
need in COM-B means that this model may be sub-optimal in designing HIVST interventions, and 
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1. Background & literature review 
In this first section of my thesis I begin by outlining some of the key considerations regarding HIV 
testing in the UK, including the history of HIV testing intervention development. I then describe the 
development and introduction of HIV self-testing (HIVST) before reviewing relevant literature in the 
UK and internationally. Finally, I describe SELPHI, the largest HIVST randomised controlled trial (RCT) 
of HIVST in a high-income setting, a trial much of my thesis wraps around.  
The HIVST literature review which begins at section 1.2 is drawn from a systematic mapping exercise 
which is a collaboration led by myself, involving the World Health Organization (WHO) and others 
(protocol available in appendix 1). I established this systematic map to capture all HIVST literature 
published in the academic press as it emerged, with searches updated monthly. I took this approach 
in recognition that the HIVST literature was rapidly developing during the early stages of my PhD. 
This systematic map has supported the development of 4 separate systematic reviews, and an 
update to the WHO HIVST guidelines launched Dec 1st 2019 (1), and in which I took an active role 
leading the key populations meta-analysis and the qualitative analysis for the values and preferences 
review. Although this section is not drawn from these reviews, I used the results of this map for my 
literature search to illuminate key areas of enquiry. Further, sections of my literature review are an 
updated version of an invited review I wrote for Current Opinion in Infectious Diseases (2). 
1.1 HIV testing in the UK 
The HIV epidemic among men who have sex with men (MSM) in the UK remains a significant public 
health challenge. Reducing the time between HIV infection and diagnosis is a key goal with national 
guidelines recommending MSM test annually, or more frequently in the presence of additional risk 
factors, such as condomless anal intercourse (CAI), sexualised drug use or diagnosis of a sexually 
transmitted infection (STIs) (3, 4). Rapid diagnosis of HIV has implications not just for individual 
health, with evidence indicating that suppressive antiretroviral therapy (ART) is beneficial at any CD4 
count, but also for onward transmission of HIV (5-7). Sixty to eighty percent of HIV transmissions are 
thought to occur from those as yet undiagnosed and often in the early stages of HIV infection where 
risk of onward transmission is greatest (8-10). The ‘Test and Treat’ approach has been enshrined in 
the UNAIDS global 90-90-90 targets which aim, by 2020, to achieve 90% of people with HIV being 
diagnosed, 90% of those diagnosed taking ART, and 90% of those on ART achieving virological 
suppression (11). The UK has been successful in this regard; in 2017 92% of people with HIV knew 
their status, 98% of those were receiving treatment and 97% of those receiving treatment had 
achieved virological suppression (12). Evidence suggests that frequency of testing remains sub-
optimal however, with 25% of MSM in the UK having never tested for HIV and 50% not testing 
annually (12-15). Ever and repeat testing is also vital for effective use of pre-exposure prophylaxis 
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(PrEP), a key driver in the decreases observed in HIV incidence (16). Further, there is growing 
concern about individuals who fall into the remaining gaps in this cascade. It is possible that the 
focus on reaching each 90% will mean the most disadvantaged with the highest needs will be 
overlooked, thereby potentially exacerbating health inequalities (17).  
The public health drive to increase testing rates has led to a significant evolution in the types of HIV 
testing interventions available, and the assays used within these interventions, facilitating 
incremental evolution of testing approaches seeking to overcome testing barriers. These barriers 
occur at patient, health care provider, health care service and health system level (18). Commonly 
cited examples of barriers to HIV testing for MSM in high income settings include: fear of a positive 
result; concern about stigma from health care providers; concern about confidentiality; service 
inaccessibility; the emotional impact of the time between undergoing testing and receiving the 
result; concerns about the time between infection and the ability of tests to detect HIV (the ‘window 
period’) and a lack of risk perception which reduces motivation to test (18-20). 
The initial tests developed in 1985 relied upon antibodies to detect HIV and required a laboratory to 
process, leading to significant waiting times for results and long window periods between infection 
and potential detection (21). Responding to concerns related to waiting for the outcome of 
laboratory run tests, the development and introduction of rapid diagnostic tests (RDTs) in the late 
1990s facilitated the provision of results on the same day when testing in clinical settings (22, 23). 
These developments were coupled with improvements in testing technology; tests with higher 
sensitivity were developed by including assays which measured the presence of additional 
antibodies, and by 1999, antigens, with 4th generation tests significantly reducing window periods 
while improving performance (21, 24).  
In the UK, from the mid-2000s, RDTs were utilised in community based testing programmes, 
expanding testing to settings including bars, nightclubs, sex on premise venues, community centres 
and other social venues in a response to limited accessibility of clinics and concerns related to stigma 
and homophobia (25, 26). Prompted again by barriers of privacy, stigma and inconvenience, HIV 
testing moved into the domestic sphere with the introduction of HIV self-sampling (HIVSS) in 2012 
and self-testing in 2015 (27, 28).   
Following intensive multifaceted prevention interventions aimed at MSM in the UK, new HIV 
diagnoses are showing declines in this group. However, these recent falls in new infections are not 
distributed evenly; with surveillance data indicating that London has seen the largest falls in new 
diagnoses, with the south of England, the midlands and the east of England also showing declines 
(12). Diagnoses among MSM in Wales have also fallen rapidly (12). Although initially slow to fall in 
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ethnic minority MSM, new diagnoses are beginning to fall in black MSM with less steep falls 
observed in Asian MSM, while increases have been observed among Latin American MSM (12). 
Further increases in HIV testing coupled with combination prevention activities are required to 
sustain these changes and to ensure they are distributed more equitably across the geographical and 
social groups of MSM. Indeed, evidence suggests a number of health inequalities exist amongst 
socio-demographic groups of MSM related to health service access, rates of diagnoses of STIs 
alongside variable prevalence and incidence of HIV (29, 30). This poses a serious challenge to the 
viability of sustained reductions in HIV incidence.  
1.2 HIV self-testing  
In contrast to HIVSS where a person takes a sample and posts it to a laboratory (and typically 
receives the results via text message), HIVST involves an individual taking their own sample, 
processing it and interpreting their own result (2). A positive result from HIVST is not a diagnosis; this 
requires the individual to attend a clinical setting and undergo confirmatory testing using approved 
clinical testing algorithms (2, 31, 32).  
In the early period of the epidemic, HIV was viewed as an exceptional disease by policy makers and 
clinicians because of the immense social and personal impact of an HIV diagnosis, as well as the 
potential for criminalisation in many settings (33, 34). As a result of this exceptionalism, HIVST was 
made illegal in many countries, including the UK, due to concerns over the potential for adverse 
psychological reactions with a positive result in the absence of effective treatments as well as the 
potential for coercive use (35). In recent years, the shift in perception of HIV for health professionals 
and affected communities from a nearly universally fatal illness to a chronic manageable condition 
with near normal life expectancy has led to changing attitudes towards the psychological impact of 
HIV diagnosis (2, 36, 37). These changes have led to a more permissive policy environment around 
testing, and increasing numbers of countries enacting laws or repealing legislation in order to 
facilitate the introduction of HIVST. The UK legalised HIVST on April 1st 2014, with the first 
commercially available CE marked test released the following year (BiosureTM) (2).  
As efforts continue to expand HIV testing, HIVST has been officially adopted on a global policy level, 
with the World Health Organization (WHO) incorporating HIVST into their Consolidated Guidelines 
on HIV testing services in July 2015 (38) and official HIVST guidance being published in December 
2016 (39).  
HIVST has been promoted by policy makers and professionals as a low cost alternative to facility-
based testing, reducing barriers such as stigma and opportunity cost while increasing patient choice 
and enhancing autonomy (2, 32, 40). The potential role for HIVST in expanding testing to new groups 
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and enabling increased testing frequency in those at highest risk is mooted (2, 40). Evidence to 
support these assertions is scarce in Europe more broadly and the UK specifically.  
HIVST also has potential application in combination HIV prevention initiatives such as the targeted 
expansion of testing, treatment and pre-exposure prophylaxis (PrEP) (40, 41). HIVSTs are available 
using a whole blood sample, usually from a finger prick, or using oral fluid. Only blood-based self-
tests are commercially available in the UK at this time, although oral fluid self-tests are widely 
available in other countries (2). HIVSTs are currently only available using 2nd and 3rd generation 
assays, meaning that window periods are typically around 6 to 12 weeks long, although RDTs which 
use 4th generation assays exist which will likely be repackaged for future self-testing use (2). 
A note on terminology: as in much of the published literature (42-52), in this thesis I use the term 
‘positive’ rather than ‘reactive’ when referring to an HIVST result that suggests HIV infection. 
Although these results clinically would be referred to as reactive (53), all available HIVSTs in the UK 
describe such a result as a positive in the instructions and it is therefore how end users understand 
and interpret these tests. This reflection of language is especially important for qualitative health 
research which seeks to develop nuanced understandings of how individuals perceive and 
experience their own health (54, 55).  
1.3 Existing HIVST evidence 
The HIVST evidence base in Europe generally, and the UK specifically, is not as well developed as in 
other WHO regions. The existing evidence also largely relates to acceptability and values and 
preferences studies, with limited data from pilot and demonstration projects. 
Acceptability studies seek to understand which populations might have need for an intervention, 
how different groups might respond to implementation and whether the intervention in question (or 
its constituent components) meets their needs (56). To aid in intervention planning, values and 
preferences studies examine how local contexts and differences in populations influence the way 
that preferences related to interventions are constructed (57). For HIVST, both study types tend to 
include participants who have not actually experienced HIVST themselves and to whom the 
intervention is therefore hypothetical. For that reason, this evidence base must be carefully 
evaluated, acknowledging the limitations of this approach. For example, when innovations in 
interventions are considered without prior experience, concerns around one’s own abilities to 
engage with an intervention or to carry out the required steps may be exaggerated as individuals will 
usually not have had sufficient time to familiarise themselves with the technology in question (2). 
Another issue is that populations do not take-up interventions evenly, and there will be key 
differences in the motivations and real-world use of those who take up the intervention at various 
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stages of roll-out (58). Rogers describes five categories of adopters of novel innovations: innovators, 
early adopters, early majority, late majority and laggards (59). Through processes of cultural 
dissemination surrounding the use of novel technologies, later adopters and laggards learn from 
innovators and early adopters through diffusion through cultures (59, 60). It has been argued that 
this process of cultural dissemination has occurred with PrEP, which was first provided in England in 
2012 through the PROUD study, and could be replicated with the experience of HIVST in European 
countries (61). Nevertheless, attending to this evidence of hypothetical potential HIVST users 
remains worthwhile because it provides an indication of how populations are likely to engage with 
the technology, and whether interventions are acceptable as well as how they might be tailored to 
ensure they are feasible and effective, while still countering concerns raised in early research.  
Table 1 details the features and findings of key HIVST studies conducted in Europe to date. When 
reviewing this evidence base, some key insights emerge.  
Generally speaking, confidentiality, convenience, immediacy and the opportunity to increase testing 
frequency are commonly cited benefits of HIVST (27, 28, 32, 48, 49, 62-64). Barriers include concerns 
around dislocation from care pathways, the possibility of coercive testing practices and perceived 
issues with self-efficacy and kit accuracy (27, 47, 65).  
Firstly, as discussed above, the majority of published studies are prospective in that very few 
individuals had experienced HIVST (66), or were conducted with stakeholders (67).There are 
however two demonstration projects included, both of which include important insights for HIVST 
service development regarding intervention reach and potential delivery settings (68, 69).  
The prospective nature of most of the data means that although we can have an understanding of 
HIVST’s potential, the current evidence base is insufficient to provide a broader overview of the 
contexts in which target populations might use HIVST. Further, three of the studies from Europe 
reporting on previous lifetime HIVST use were conducted before licenced, regulated tests were 
widely available in these countries. Kits being used were therefore unregulated RDTs bought online 
in three studies (66, 70, 71). One demonstration project used an RDT intended for clinical use which 
was adapted without formative research, raising potential concerns around usability (69). Two 
studies found moderate to high willingness to use a potentially regulated (but at the time 
hypothetical) HIVST (15, 66).  
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Table 1: Key HIVST studies from Europe 
 






Study type Aim Key findings 
















Acceptability To describe awareness and 
willingness to use the self-test and 
the perceived barriers and facilitators 
to implementation. 
• Self-test awareness was moderate among MSM (55%), and 
willingness to use was high (89%).  
• Greater awareness associated with higher educational 
attainment & previous STI testing.  
• Willingness to use was associated with meeting sexual 
partners online.  
• Experts highlighted the overall acceptability of self-testing; 
it was understood as convenient, discreet, accessible, and 
with a low burden to services. 
• Ambivalence related to reduced opportunities to engage 

















To determine feasibility/acceptability 
of HIV home/self-testing. 
• 513 oral fluid kits posted (adapted version of professional 
use orasure test). 
• 19% of sample completed study follow-up. 73% were men 
who have sex with men (MSM). 47% had never tested 
previously; 37% MSM had never tested. 
• 2 infections identified, partner notification identified one 
further. 
• HIVST reduced barriers to clinic access and to using blood 












Acceptability To identify whether men who have 
sex with men (MSM) who use dating 
or sex websites or gay or HIV 
community websites would be 
interested in accessing these tests if 
reliable ones were authorised, their 
reasons for being interested or not, 
and independent variables associated 
with being interested. 
• 86.5% (5109/5908) reported interest in using HIVST.  
 
Variables associated with higher interest: 
Never tested, tested >12 months ago, CAI with casual partner, 
not open about sexuality, living in town >100,000 inhabitants, 
living in family with a wife and/or children or with one’s 
parents, having 2 to 50 casual partners in preceding 12 months, 












Study type Aim Key findings 
• Convenience, accessibility, can do it at home. 
• Rapidity obtaining test results.  
















Acceptability To identify and compare the 
information and support needs of the 
different target population groups. 
263 policy & health service recommendations groups into eight 
themes 
Themes 
1. Communicating at both national and community levels 
about self-test arrival 
2. Providing information adapted to the different community 
groups’ needs  
3. Providing counselling on self-test use and access to care  
4. Making self-tests available to all in terms of accessibility and 
cost  
5. Preparing community healthcare and screening systems for 
the arrival of the self-test  
6. Approving only high quality self-tests 
7. Defending self-test users’ legal rights  












Acceptability To validate findings about the 
frequency of self-testing and to 
investigate consumers' follow-up 
behaviour after performing a self-test 
by assessing the actions taken by self-
testers. 
• 1.9% had used an HIVST 












Feasibility To assess the ability of lay users 
attending a sexual health service to 
perform the BioSure HIV Self-Test 
and to correctly interpret the result 
of the self-tests.   
• 97% (95% CI 93.5 – 98.9) conducted the test properly.  
• 99.5% correctly identified the test result. 
• Participants correctly interpreted the result of 94.0% (95% 












To evaluate the acceptability and 
feasibility of using vending machines 
in a sex on premise venue (sauna) to 
distribute HIVST to men who have 
• 265 testing kits were dispensed (number of men 
unknown). 
• Mean age 31 years (range 18–70). 
• 4% (n = 7) had never tested for HIV before and 11% (n = 
22).had tested within the last 1–5 years. 
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Study type Aim Key findings 
premise 
venue 
sex with men at high-risk of 
contracting HIV. 
• Uptake of HIV  tests  was  six  times  greater  via  the  
vending machine  compared with testing conducted by 
community outreach workers in the same venue and study 
period. 
• HIVSTs perceived to lower barriers to testing, especially 
those related to stigma while increasing convenience. 
• Concerns about positive result with no support. 










Acceptability To identify which groups of MSM in 
England are less likely to have tested 
for HIV and their preferred model for 
future tests. 
• Younger men, older men and men who were not gay 
identified were least likely to have tested for HIV.  
• Groups less likely to test in line with guidelines were more 
likely to report wanting to access HIVST for their next test.  
• MSM who had never tested preferred self-administered 
testing options (HIVSS & HIVST) for their next test.  
• Higher educational attainment, migrancy, black ethnicity 
and being at higher of risk were associated with greater 
levels of HIV testing. 
Key findings in bold 
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Although formative studies provide some insights into groups who might benefit from HIVST, these 
data have significant limitations. A key issue is that contact with the technology and discussions 
amongst peer groups will shape acceptability profoundly, so most of this evidence is only indicative 
of intervention potential at the outset of availability, not acknowledging how individuals will engage 
with the limitations of possible interventions. Finally, with the notable exception of Flowers et al. 
(28) and Vera et al. (68), both of which are mixed-methods investigations, all studies are quantitative 
and lack the depth of understanding needed to inform effective intervention development and to 
optimise service provision. Astonishingly little data exists about the values and preferences of MSM 
in Europe for HIVST interventions, a key component of service design and delivery (2). 
The demonstration projects by Gibson et al. (2016) and Vera et al. (2019) are important building 
blocks in the HIVST literature, with some limitations. Gibson (et al. 2016) demonstrated that HIVST 
delivered online can reach those who do not test in line with national guidelines (69). A 19% follow-
up rate in this study demonstrates the challenges of engaging with those who have received an 
HIVST following online delivery of the intervention to collect information on their results and provide 
support if necessary (69). This high attrition also makes it impossible to generalise the findings. 
Important data about experiential concerns around ease of use and acceptability were not collected, 
a particular concern given the test was an oral fluid kit designed for clinical use and adapted by the 
researchers for self-use. The accompanying information may therefore have been insufficient.  
Vera et al. (2019) demonstrates that it is feasible to deliver HIVST through innovative mechanisms 
such as vending machines in public premises (68). This demonstration project however 
predominantly reached a group of MSM with less pronounced testing needs than Gibson et al., 
raising the possibility that these strategies may be sub-optimal when compared to online delivery if 
expanding testing to those less likely to test is a key objective. Furthermore, efficiency of service 
delivery is a potential issue with a small number of kits having been distributed in this demonstration 
project, although the intervention did outperform the community testing and counselling initiatives 
in the same venue (68). 
Looking more broadly, MSM in many middle- and high-income settings are relatively well 
represented in literature around HIVST acceptability as well as research investigating values and 
preferences (studies that show the diversity in preferences around intervention design and 
characteristics). Emerging evidence amongst MSM from Peru (44, 76), the USA (62, 63), Vietnam (64) 
and Mexico (77) report that MSM find HIVST highly acceptable, with moderate acceptability 
observed in Hong Kong despite the availability of HIVST (45). These studies are heterogeneous in 
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their acceptability measures, variously using willingness to use, quantitative acceptability metrics 
and qualitative descriptions of acceptability.  
A systematic review conducted by Figueroa, Johnson (32) among key populations (MSM, sex 
workers, trans people, people who use drugs and people in prisons) suggests that oral fluid self-tests 
are marginally preferred over finger stick or whole blood tests, although this tends to vary across 
country income settings and key populations (32). In a study in Vietnam, MSM and female sex 
workers (FSW) preferred oral fluid HIVSTs, while people who injected drugs preferred blood based 
kits (64). In work from the US conducted with an ethnically diverse group of high risk MSM, more 
frequent testers preferred blood based testing, whereas men who tested less frequently preferred 
oral fluid HIVSTs (78). MSM who prefer oral fluid testing in the literature tend to value painlessness 
(79) while those who value blood based testing generally feel it is more accurate (48, 79, 80). 
A range of feasibility studies, demonstration projects and trials globally have provided data on the 
feasibility and acceptability of providing HIVST to different populations through an array of 
intervention designs. While the aims for each study vary, designs tend to fall into one of two 
categories: the first aims to detect longstanding prevalent infections, the second to increase 
frequency of testing in those at risk of acquiring HIV, particularly in risk groups with high incidence. 
Both types of study also tend to have cost containment as a goal as HIVST may be a useful 
diversionary tactic from “bricks and mortar” services, thus reducing demand on resources (2).  
Feasibility and pilot HIVST studies provide some evidence that HIVST will perhaps detect 
undiagnosed prevalent infections in individuals who do not test in line with guidelines or have never 
tested, although it remains unclear if HIVST is more efficacious than other testing interventions to 
meet this aim. Projects in the US which focussed on reaching groups who have not previously tested 
or have difficulty accessing services seem to be successful in reaching MSM online (69, 81) and, to an 
extent, in sex on premises venues (51). For definitive evidence regarding the potential for HIVST to 
detect prevalent infections more quickly than other interventions we require RCTs powered to 
detect differences in rates of diagnosis. 
Efforts to increase the frequency with which at-risk groups with high HIV incidence test are central 
to aspirations around the expansion of HIVST, and increased frequency of testing is a key benefit 
often repeated in values and preferences studies conducted with key populations. Non-RCT projects 
which have provided participants with a number of HIVSTs with instructions to test frequently have 
demonstrated that this intervention approach is feasible among transgender women in San 
Francisco (49), and MSM in Brazil and Peru (76). 
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Although these feasibility, demonstration and pilot studies provide valuable insights into basic 
elements of service delivery, there is a distinct lack of data on service uptake by demographic and 
behavioural groups with testing needs and documented utility for HIVST, such as MSM with lower 
educational qualifications, black MSM, those who are not gay identified, as well as both older and 
younger MSM (15, 82). These publications therefore provide relatively little insight into how HIVST 
might be a useful tool in responding to issues concerning health inequity or, conversely, the 
potential for HIVST to exacerbate existing inequalities. Although they have been conducted in a wide 
range of geographical locations with a range of populations, very few have been conducted in 
Europe and no RCTs have been conducted in the region. Sample sizes have also been very small in 
the quantitative studies. Qualitative work has thus far not had a prominent place in research 
initiatives providing HIVST, leading to significant gaps in our understanding of the experiences of 
individuals who have used the technology. This is especially important for widespread provision, 
which relies on intervention designs that meets the needs of a very wide variety of MSM. The 
absence of European evidence in this regard is especially problematic as the structures and 
accessibility of health systems in the European Region are vastly different to that of the US and Latin 
America, where much of this evidence originates.  
Although mixed, RCT evidence related to HIVST provides some important insights. HIVST has 
increased testing uptake among MSM in all RCTS conducted (83-87). However, with the exception of 
Wang et al 2018 and Jamil et al 2017, most of these studies suffer from multiple sources of potential 
bias, including self-reported outcomes which were not validated by the study teams (83-88).  
In terms of testing frequency in RCT evidence, in Seattle, MSM self-reported testing significantly 
more frequently when provided with multiple HIVSTs compared to standard of care (SoC) (5.3 tests 
compared with 3.6 over 15 months) (89). The study was too small (n=230), however, with too few 
reactive results (n=2) to show an effect on increasing HIV diagnosis or on linkage to care (83). These 
findings were repeated in an RCT among in MSM in Australia which showed increased testing 
frequency among the self-testing group that did not reduce attendance in STI clinics, indicating that 
men in this study used HIVST largely as a supplementary testing option. Two further US studies also 
showed increases in testing frequency (84, 85). Encouragingly, in Jamil et al 2017, frequency was 
increased in both those who tested annually or more often and those who did not.  
A critical issue is that RCT evidence in regards to increasing rates of HIV diagnosis compared to other 
approaches through HIVST is not strong as studies have thus far been underpowered to assess rates 
of diagnosis compared to SoC. In addition, rates of reactive HIVSTs are an extremely challenging 
outcome to validate in the absence of surveillance databases that capture new infections. However 
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one recent RCT found more infections in the HIVST arm vs the SoC arm, a result which was 
statistically significant (HIVST = 12 of 1325 [0.9%] vs SoC = 2 of 1340 [0.1%]; P < .007) (84). 
Linkage to care for confirmatory testing and linkage to care including early ART is necessary 
following a reactive result from a HIVST. There is very limited evidence from high-income settings of 
linkage rates after positive HIVST compared with other testing interventions, and that which does 
exist is not statistically significant (83, 86, 88). 
1.4 An HIV Self-testing Public Health Intervention (SELPHI) 
This PhD is embedded in the SELPHI study, the first HIVST RCT in the UK. SELPHI is also the first RCT 
globally which attempts to address both the ability of HIVST to detect undiagnosed prevalent HIV 
infections more effectively than current SoC though the offer of a baseline HIVST and also to reduce 
the time between HIV infection and diagnosis through the offer of repeated HIVST in men at higher 
risk of HIV infection. SELPHI launched in February 2017 and recruited 10,135 MSM and transgender 
people. The primary outcome was rates of HIV diagnosis as determined through confirmatory testing 
and linkage to care assessed through linkage with the UK national HIV surveillance database. This 
RCT will provide vital evidence for policy makers in high-income settings and those working with key 
populations on the efficacy and cost effectiveness of HIVST in increasing rates of HIV diagnosis. 
Intervention development for SELPHI has been underpinned by the Behaviour Change Wheel (BCW) 
system which includes the COM-B model of behaviour change (discussed further in section 2.2). This 
model emphasises that changes in capability, opportunity and motivation are required to support 
individuals in enacting and sustaining behaviour change (90, 91).  
SELPHI is an online study with two randomisations: randomisation A occurred at baseline and 10,135 
eligible MSM and transgender people were randomised to receive either one free HIV self-test (60% 
of participants) or none (SoC, 40% of participants). At 3 months 2,325 eligible participants drawn 
from those allocated to baseline HIVST in randomisation A (RA), who were at ongoing risk of HIV 
infection and who expressed an interest in receiving more HIVST kits were randomised through 
randomisation B (RB) to either a regular (3-monthly) offer of additional self-tests (50% of 
participants) or SoC (50%). See Table 2 for full eligibility criteria by randomisation.  
Participants were recruited to SELPHI through geo-location socio-sexual networking applications 
(often referred to colloquially as ‘hook up’ apps) and social media. Most advertisement was paid, 
with some reliance on organic reach through community-based organisation (CBO) dissemination 
and media engagement. The first 1,000 participants were recruited during a soft-start phase 
(February to April 2017), during which a variety of advertisement approaches were tested. Following 
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analysis of data relating to this, SELPHI launched in earnest in July 2017. Recruitment was completed 
on 28th February 2018. 
Table 2: Edibility criteria by randomisation 
Randomisation A Randomisation B 
MSM including cis & trans men, trans women  Allocation to baseline test in Randomisation A 
Lifetime anal sex  Completed 3-month survey 
Not previously diagnosed with HIV Remains HIV negative 
Aged ≥16 Expresses interest in further HIVST kits 
Resident in England or Wales CAI with ≥ 1 partner in preceding 3 months 
Willing to provide name, date of birth and 
email address 
Used HIVST kit 
Consent to link survey responses to surveillance 
and clinic databases 
 
Not previously randomised in study 
When participants signed up online, they first provided informed consent, then completed a survey 
detailing eligibility criteria. They were then sent a second survey via email in which they were asked 
for additional demographic and behavioural information and other details required to send the 
HIVST kit and to subsequently link to the national HIV surveillance database to detect any future 
confirmed HIV diagnoses. Following randomisation, participants allocated to baseline testing (BT) 
were sent a kit through the post. After two weeks they received a survey asking whether the kit was 
used. At three months, a further survey was delivered to those in the BT and no baseline testing 
(nBT) groups; this asked for sexual behavioural information and determined eligibility for 
randomisation B. Those eligible were then randomised either to repeat offers of HIVST kits or SoC. 
Trial participants were matched with their clinical records through the HIV surveillance database 
held at Public Health England (PHE) through which endpoints were recorded. See Gabriel et al (92) 
for the full trial protocol.  
2. Approaches and methods 
My thesis informs SELPHI by generating key social science evidence before and during the trial. This 
provides a significant body of work suitable to inform self-test service provision and contribute more 
broadly to academic understandings of self-testing for HIV in MSM in England and Wales. My thesis 
includes several stages: it responds to pre-implementation questions regarding values and 
preferences of the intended beneficiaries as well as motivations for access and likely contexts of use. 
My attention then turns to questions of intervention feasibility and acceptability, specifically 
exploring the ease of use of the kit, preferences around intervention design and the real world use 
of HIVST among beneficiaries. This deepens the evidence base for others seeking to implement 
HIVST in similar settings. Finally, my thesis explores the contribution of HIVST to the lived 
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experiences of HIVST users, providing valuable data about the benefits and limitations of HIVST 
should it be made widely available, as well as potential for intervention adaptations. It also 
investigates the utility of the COM-B model of behaviour change (explored further in section 2.2) for 
conceptualising HIVST interventions.  
This PhD aims to develop an understanding of the potential contribution of HIVST to the well-being 
of MSM in England & Wales.  
The specific objectives are: 
i. To examine the values and preferences of MSM for HIVST interventions considering key 
domains of intervention design. 
ii. To explore the potential barriers and facilitators of HIVST for MSM using COM-B as a 
framework. 
iii. To understand how HIVST compliments existing testing strategies considered or adopted by 
MSM. 
iv. To assess the feasibility of recruiting MSM to the SELPHI pilot, and the acceptability of the 
HIVST intervention among those randomised to receive a kit.  
v. To explore the experience of utilising HIV self-tests and the implications for further 
intervention development and scale-up.  
vi. To explore how components of the SELPHI interventions impact on behaviour for, and are 
experienced by, RCT participants.  
vii. To examine the utility of COM-B as a useful model for understanding behaviour change in 
relation to the provision of HIVST. 
This thesis has been embedded within a broader programme of work as part of a multi-institutional 
study. The team I have worked within is known internally as workstream one (WS1), which is largely 
separate from workstream two (WS2), the clinical trial group responsible for RCT delivery. WS1 
contains all feasibility work for the trial and has had responsibility for all social science aspects of the 
programme grant. Within this team I have been given responsibility for the design, conduct and 
analysis of the studies we have undertaken to date, with guidance and support from my more senior 
colleagues. The aims and objectives used for each study have been produced by me with input from 
my wider team, and differ significantly from what was specified in the funding bid. This has provided 
me with the scope to form study questions relevant not only to the SELPHI RCT, but which also make 
a significant contribution to HIVST and the behaviour change literature more broadly. For each study 
used in this thesis I have created the data collection instruments, conducted the research, designed 
the analysis tools and carried out the analysis.   
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2.1 Thesis overview 
 This PhD, comprised of three studies presented over five results papers, employs a range of 
methods suitable for addressing specific questions relevant to the generation of high-quality 
evidence around the potential of HIVST in England and Wales. Section 2.2 describes my conceptual 
grounding and 2.3 outlines my theoretical basis for this pragmatic multi-method approach. Table 3 
provides an overview of methods used in responding to each objective.  
The first study used focus group discussions in taking a prospective approach to exploring HIVST 
acceptability; motivations and barriers; and values and preferences for HIVST among MSM in 
England. This formative inquiry has sought to overcome previous issues with prospective HIVST 
research by including the demonstration of kits, thereby providing some HIVST exposure during the 
discussion. This study also provides additional evidence on the ways in which the technology might 
be adopted by MSM based on normative understandings of HIV testing narratives. This study 
responds to objectives i, ii and iii and contributes papers 1 & 2 to my thesis. 
The second study (which responds to objective iv and contributed towards paper 3 of my thesis) 
shifts to understanding implementation considerations for HIVST during the pilot phase of SELPHI. 
This study uses quantitative trial data alongside in-depth interviews which provide additional depth 
to the analysis. This study explores feasibility and acceptability of the intervention through 
evaluation of the recruitment strategy used for the pilot phase, investigating the proportions in 
receipt of the intervention who use the kit (and reasons for non-use), as well as acceptability of the 
intervention. This paper primarily uses quantitative longitudinal study data from three time-points 
with results from qualitative interviews undertaken during the pilot phase adding depth and context.  
The final papers of my thesis respond to objectives v through vii and present the findings of an 
evaluative in-depth interview (IDI) study with SELPHI participants in which the outcomes related to 
HIVST are examined from the perspective of those in receipt of HIVST. In-depth interviews were the 
most appropriate method of data generation as they provide the opportunity to explore issues in 
greater depth with individuals, without necessarily generating normative understandings in the way 
that focus group discussions do. This has enabled the exploration of tensions within the data and the 
development of nuanced understandings of the potential of the SELPHI interventions and HIVST 













of HIVST to 
the well-being 
of MSM in 
England & 
Wales. 
Study Objective Methods Paper 
Study 1: 
Formative 
i. To examine the values 
and preferences of MSM 
for HIVST interventions 
considering key domains 
of intervention design. 
Qualitative analysis of focus 
group discussions 
1 
ii. To explore the 
potential barriers and 
facilitators of HIVST for 
MSM using COM-B as a 
framework. 
Qualitative analysis of focus 
group discussions 
1 
iii. To understand how 
HIVST compliments 
existing testing strategies 
considered or adopted by 
MSM. 
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depth interviews with trial 
participants 
5 
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relation to the provision 
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2.2 Conceptual approach  
2.2.1 Implementation Science  
In addressing these objectives, this PhD is situated within the interdisciplinary field of 
implementation science (IS). IS can be described as: the scientific study of methods to promote the 
systematic uptake of research findings and other evidence-based practices into routine practice, and, 
hence, to improve the quality and effectiveness of health services (93, 94). It is an approach 
inherently concerned with the effective design and implementation of health interventions through 
robust theoretical development and the subsequent adoption of interventions into widespread 
practice (95, 96). It seeks to ensure high quality interventions are developed and evaluated so that 
they have optimal benefits for their individual recipients while also examining potential for other 
contexts (95).  
This PhD generates a high-quality evidence base on self-testing and the potential innovations that 
can be adopted and implemented on a national scale. This evidence can also be used to inform 
implementation in other contexts. This PhD specifically addresses questions about intervention 
design, implementation, feasibility, acceptability, reach and adoption (95). In terms of intervention 
design and development, and in line with IS approaches, I focus on context, specific intervention 
components and the demographic and behavioural characteristics of individuals who are 
beneficiaries (95).  
I take a hybrid approach to IS, drawing on the traditions that are most useful in meeting the 
overarching aim of this thesis. Nilsen (2015) describes three theoretical approaches to IS: describing 
and/or guiding the process of translating research into practice; understanding and/or explaining 
what influences implementation outcomes and evaluating implementation (97). My thesis primarily 
employs the second of these, using implementation theory to enhance understanding of critical 
issues relevant to HIVST (97). Doing so allows for the prioritisation of the most critical issues which 
can influence implementation, thereby increasing the appropriateness of interventions by 
documenting and responding to patient need (97). 
In the synthesis stage of my thesis I employ a determinant framework to develop nuance and 
contextualise my results (97). Determinant framework approaches focus on the factors that can 
influence implementation and adoption, investigating barriers, facilitators and their interaction with 
qualities of end users (97, 98). These approaches recognise that implementation is a 
multidimensional phenomenon and that understanding influences on outcomes is a critical area of 
inquiry (97).  
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I use the Consolidated Framework for Implementation Research (CFIR) (95, 97), as a lens through 
which to synthesise many of the results generated in this thesis. This determinant framework posits 
that successful implementation and translation of interventions to new contexts is contingent on 
adequate attention being paid to five key domains (95, 97-99). The first domain, the intervention, 
contains all characteristics of the intervention which is being implemented, acknowledging that 
many interventions come into organisations as a poor fit (95). The second and third components, the 
inner and outer settings, provide recognition that context shapes intervention delivery, especially 
the structural, political, economic and social contexts through which intervention implementation 
proceeds (95). The fourth domain, the individuals involved in implementation, recognises that 
individuals in an organisation have agency to shape or to hinder delivery (95). The fifth domain 
refers to the process of implementation which is contingent on the organisation implementing the 
intervention (95).  
CFIR has been used in a wide range of study designs, although it is most commonly used during and 
post implementation to investigate the experiences of those implementing an intervention (99, 100). 
Using this framework prospectively provides potential policy makers with additional insights into 
intervention implementation considerations identified in this thesis (100).  
2.2.2 COM-B  
The primary model informing this work is a systematically developed behaviour change model from 
IS, the BCW which includes the COM-B model. This system was chosen for this PhD because of its 
systematic development and clarity; the BCW and COM-B incorporate domains covered in pre-
existing behaviour change models, but arguably in a more coherent way.  
This system was developed by Michie and colleagues as a novel way of describing an array of issues 
to examine when seeking to improve the design of behaviour change interventions. It was 
developed under the premise that pre-existing models did not fully encompass the range of possible 
domains which could influence outcomes (91). In developing the BCW and COM-B, Michie and 
colleagues consolidated theorised behaviour change constructs, interventions and policy approaches 
from 19 frameworks to create a structured system with inter-related levels (91).  
At its most basic, the COM-B model asserts that capability, opportunity and motivation interact to 
shape behaviour, which in turn also interacts with those three domains (see figure 1). Each of these 
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domains is divided further into additional sub-domains to more comprehensively represent the ways 
in which behaviour is influenced at this level.  
According to Michie et al; (91) 
Capability is defined as the individual's psychological and physical capacity to engage in the 
activity concerned. It includes having the necessary knowledge and skills. Motivation is defined 
as all those brain processes that energize and direct behaviour, not just goals and conscious 
decision-making. It includes habitual processes, emotional responding, as well as analytical 
decision-making. Opportunity is defined as all the factors that lie outside the individual that 
make the behaviour possible or prompt it. 
When used in developing interventions, one must consider which of these elements require 
modification in order to support behaviour change on the individual, community or population level 
(91, 101). For example, one might have the capability and motivation to change behaviour, but not 
the opportunity. Or, more realistically, there may be subtle modifications needed in more than one 
domain and supporting change in multiple areas may be required (91). The benefit of this structure 
is that it provides a simple and straightforward way to categorise influence on behaviour and is easy 
both to understand, and to apply.  
The BCW (figure 2) elaborates on the basic model by providing an expanded framework for 
conceptualising the relationship between the pre-conditions of behaviour change, intervention 
functions and policy (91). The first level consists of the basic COM-B model (capability, opportunity 
and motivation). One level outwards are intervention categories that aim to address barriers or 
 
Figure 1: COM-B basic structure (Michie et al 2011). 
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required alterations in the first level. Finally, the outmost level is formed of policy approaches and 
categories that facilitate interventions. COM-B provides an articulation of both the intervention and 
policy areas which can be used to target each COM-B domain. Because the UK has a supportive 
policy environment represented by the HIVST technology being legalised in 2014 alongside 
associated regulation and supportive guidelines, and because SELPHI represents a form of service 
provision, for the constituent studies in my thesis I use only the intervention approaches (2). 
The BCW and COM-B were chosen for use in this thesis for several reasons. It was indicated that 
COM-B would be used in formative research in the initial funding bid for the programme grant in 
which my work is embedded. I chose to continue using it partly for pragmatic reasons, leading to a 
more coherent body of work than would be the case if I switched between models. This has added 
depth and nuance by including a consistent lens through which these findings are viewed. 
Further, the BCW and COM-B are especially useful because of their systematic development: the 
range of behaviour change constructs and theories represented within their production mean that 
they cover a wider range of influences on behaviour than many other models do. For example, the 
health belief model does not incorporate the role of some psychological processes such as habit and 
self-control (91). COM-B also has the benefit of being much simpler than TDF (90), increasing its 
utility through clarity.  
The Theory of Planned Behaviour has a more elaborated concept of motivation and takes greater 
account of norms than COM-B making this an obvious choice for interventions seeking to modify 
behaviour which is heavily shaped by norms drawn from community and society (103, 104). This 
theory however has no space to theorise how a physical technology (such as an HIVST) can be 
provided within interventions, vastly limiting its utility in this context. It has also been much 
criticised for an overt focus on rationality, assuming that individuals will behave in specific ways in 
response to norms, ignoring differences across individuals and groups (104). Finally, the Information-
Motivation-Behavioural Skills model could have been a promising approach given the need to 
develop capability in using HIVST and its wide application in HIV focused interventions (105); it too 
however suffers from a lack of conceptualisation around the potential of technology to shape 
behaviour.   
The simplicity, organisation and clarity of the domains in the overall BCW system and their 
relationships to intervention functions mean that it is a useful model for planning interventions and 
theorising how intervention components can work together to produce behaviour change. The basic 
capability, opportunity & motivation structure provides flexibility within the model to consider a 
wide range of intervention processes and their impact on behaviour, as well as logical causal 
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mechanisms. The basic structure of COM-B allows for considering how the provision of a technology 
and the intervention components supporting that provision can work together to shape and 
encourage behaviour change. For example, the targeting of an intervention may seek to enhance 
motivation (either reflective, automatic or both), while the provision of a technology could alter 
both capability and opportunity, depending on the end user. This is a major benefit compared to 
other models, which often are only applicable to purely psychosocial interventions. 
The BCW and COM-B do have some key weaknesses specific to this work. While the basic structure 
(figure 1) is very useful for considering interventions delivering novel technologies, the expanded 
wheel (figure 2) is arguably less attentive to this. Although Michie and colleagues state that the 
enablement intervention category in the intervention processes level refers to pharmacological and 
technological interventions, their approach lacks an understanding of the ways in which 
technologies work to produce behaviour change themselves. For example, the use of, or 
engagement with, a technology will logically produce certain behaviours as a result of engagement 
in that process, a discourse which is absent from the BCW and COM-B model. This is perhaps key to 
understanding behaviour change in an environment of increasing bio-medicalisation of risk, and 
medicalised approaches to self-management which increasingly rely of the adoption of novel 
technologies (106, 107).   
Another important weakness related to this model is that the concept of ‘need’ is largely absent. 
Although motivation is described, the model itself does not acknowledge different types of need and 
the ways in which they are enacted. For example, in Bradshaw’s taxonomy of need, four types are 
described: normative need; felt need; expressed need and comparative need (108, 109). Normative 
Figure 2: COM-B behaviour change wheel (Michie et al. 2011). 
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need is socially produced, felt need is a want or desire which has yet to be described. Expressed 
need is a felt need turned into action, and comparative need is generated through interactions with 
medical staff and health services (108, 109). The BCW and COM-B rely on felt need being converted 
to expressed need, with a small degree of acknowledgement of normative need. Comparative need 
is absent, despite it potentially being a major influence on health seeking behaviour.  
The under representation of normative need is a symptom of a broader issue with COM-B which is 
that social influences on barriers, facilitators, and therefore behaviour are not given adequate 
attention. The production of these are social and structural and understanding their determinates 
are also central in addressing them. For example, participation in HIV prevention interventions 
(including testing) have become a highly normative activity for MSM and is often understood as a 
social obligation (19, 20, 110, 111). This process and this type of need are underrepresented in COM-
B despite it being a primary driver in service access for many. It is for that reason that the final 
objective of my thesis is to examine the utility of COM-B as a model to understand behaviour change 
related to the intervention.   
2.3 Multi-method approach  
This thesis employs a multi-method approach to data generation, moving from one method to the 
next to develop a comprehensive understanding of the subject matter from a range of 
methodological perspectives. This allows for the capitalisation on strengths while minimising 
weaknesses of core data collection approaches (112). Rather than mixing methods for the purpose 
of triangulation, this multi-methodology focuses on theoretical integration of separate studies in 
order to address the overarching aim of my thesis (113). This involves using separate methods, with 
separate analyses and then integrating the new understandings gained as the final step (113, 114). 
Following this approach, I have focused on making pragmatic methodological decisions while 
rejecting what Bernstein calls the tyranny of the method (115, 116). Indeed, I selected each method 
used in my thesis to respond optimally to the objective it is addressing, rather than for the paradigm 
it is aligned with.  
My thesis moves through several stages in a comprehensive data generation process. I begin with a 
prospective focus, interrogating important pre-implementation questions surrounding values and 
preferences as well as potential contexts of use. Following pilot intervention implementation, I 
investigate feasibility of intervention delivery and acceptability for those who have used HIVST. 
Finally, in a study grounded in interpretivism, the experiences of individuals are examined in greater 
depth to better elucidate how behaviour change has been facilitated for HIVST beneficiaries. This 
sequential approach to evidence generation is used often in development and implementation of 
new services and technologies in health care (117, 118).  
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Focus group discussions were the most appropriate choice for the first study in my thesis for several 
reasons. At the time this research began, little evidence existed to inform the development of an 
HIVST intervention in Europe. A major strength of focus group discussions is that they help to elicit 
normative understandings of community perspectives relating to a subject matter (119). This makes 
them especially useful for investigating new prevention technologies, their applications and 
potential reception (119).  
The second study utilises longitudinal data drawn from the SELPHI trial with qualitative data from 
IDIs. This approach has the strength of measuring the aggregate experience of those in receipt of the 
intervention, while elaborating on and contextualising findings using participant’s accounts of their 
own experience. This study is therefore led by the quantitative data with elaboration from 
qualitative sources, an approach called ‘following a thread’ (113, 120). This is especially well suited 
to acceptability and feasibility studies which can be measured in multiple ways and require a 
nuanced approach to generate useful understandings. Placing increased emphasis on quantitative 
data has the benefit of allowing a rigorous investigation into the ways in which acceptability and 
intervention uptake might vary across groups. Using qualitative data to add depth has the benefit of 
contextualising the reasons why this variation may occur and offer potential solutions to issues 
related to intervention delivery.   
For the final study, in-depth interviews have been selected for data generation. This is the most 
appropriate approach as this work is concerned with the exploration of participants’ understandings 
of their own experience in great depth, rather than the normative understandings which are elicited 
by focus group discussions. This approach enabled the collection of richer data and will help 
understand the broader influences on testing behaviour alongside accounts of experiences with 
HIVST. The focus on the broader influences of testing behaviour enables the testing of COM-B, using 
participants’ own accounts of their experience and behaviour change journeys, without the 
influence of others. This allows for the examination of the ways in which HIVST can contribute to the 
well-being of MSM in England and Wales.   
3. Results 
My thesis has three main studies and therefore three sections of results. I outline these here before 
moving onto each section in turn. 
The first study was a formative study of HIVST values and preferences investigated through focus 
group discussions with MSM in England. This formative section has two papers, one examining 
values and preferences and another elaborating on MSM’s narratives of HIVST potential. I describe 
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how this formative study and others contributed to the SELPHI logic model, a key lens through which 
the intervention was subsequently viewed.  
The second study in this thesis is an implementation study that interrogates the feasibility of delivery 
and acceptability of the intervention. This work is the lynchpin which changes focus from theoretical 
prospective questions regarding use to MSM’s actual experiences.  
Finally, my third study comprises two analyses of qualitative in-depth interviews with trial 
participants which provide important answers to key evaluative questions. Paper four in this section 
provides additional depth and nuance surrounding intervention acceptability, providing additional 
information regarding how interventions are experienced by their end users in order to support 
potential implementation. The fifth paper provides an analysis of how the SELPHI interventions 
performed when compared to our logic model, using an innovative testing typology as a lens 
through which to view divergent experiences.  
3.1 Formative research 
At the outset of the planning process for SELPHI, it was clear that there was little evidence that could 
support the design of an HIVST intervention, or strategies to deliver it optimally. My role in this early 
phase was to design a study which might help to answer some of these critical questions. Some of 
this was pre-specified in the funding bid but only at a very basic level, and development of final 
study design and methodology was left to me, supported by my colleagues.  
I therefore looked to the literature which suggested acceptability would likely be high, that oral fluid 
testing might be preferred, and support would be a key issue (32, 121). There was however a lack of 
evidence regarding delivery mechanisms, preferences around instructions or contexts of likely use in 
a setting with a diverse array of existing testing interventions. In addition, little from comparable 
contexts was uncovered about how MSM might perceive HIVST in a context of diverse service 
provision, such as England and Wales.  
In order to gain a better understanding of the groups who might benefit most from HIVST, I 
conducted an analysis of the 2014 Gay Men’s Sex Survey (publication available in appendix 2). This 
indicated that those who test less frequently and not in line with UK guidelines (older men, younger 
men, those who were not gay identified) had stronger preferences for remote testing approaches 
including HIVST and HIVSS (15). 
Using these data and taking the only available kits in the UK at that time, I designed a topic guide 
(appendix 3) and purposive sampling frame (appendix 4) to answer some of these critical questions. 
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This enabled the production of two papers which aided intervention development and made a 
significant contribution to the HIVST literature generally.   
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3.1.1 Paper 1: HIV self-testing among men who have sex with men (MSM) in the UK: a qualitative 















































The first paper gives an in-depth overview of the likely dimensions of intervention acceptability and 
how specific decisions may shape uptake (e.g. home delivery and the implications for those with 
domestic privacy concerns). This data was less useful for exploring contexts of HIVST adoption, a 
potentially key consideration for the RCT and academia more generally.  
During the focus groups it became clear that HIVST had a very specific relationship to norms around 
HIV testing, and that these would likely be highly relevant. I had used COM-B to guide the 
production of the topic guide and in initial coding, and these emerging results did not seem to fit 
well with what the model proposed. They also seemed to potentially threaten the central aspiration 
of HIVST as diagnosing incident and prevalent infections more quickly than other testing methods by 
expanding testing to new audiences (2). 
In order to explore these data more fully, in the initial analysis I included the deductive codes risk, 
reassurance and norms, and coded data relevant to these very broadly. After initial coding I 
inductively coded data captured within these, generating the analysis presented here.  
Attempts to interpret the data confirmed that COM-B could not speak to these results. The model 
did not serve as a convincing lens through which to view what I had observed. I therefore took the 
decision to look to social theory, especially to Rose and Novas’ (2003) concept of biological 
citizenship (122) and Aronowitz (2009) and Lupton’s (1995) ideas around the biomedicalisation of 
risk (123, 124). This allowed for an exploration of the narrative understandings of HIV testing among 
MSM and how HIVST may fit into these in the future.  
Paper 2 of my thesis therefore moves to understanding intervention potential based on testing 
narratives amongst intended beneficiaries. Understanding this provides a critical evidence for RCT 
design and also for the academy more generally. This paper is of direct relevance to policy makers 




3.1.2 Paper 2: Risk, reassurance and routine: a qualitative study of narrative understandings of the 







































The second paper of this thesis, Risk, reassurance and routine: a qualitative study of narrative 
understandings of the potential for HIV self-testing among men who have sex with men in England, 
provided insights into the potential contexts of HIVST use based on normative understandings of 
narratives around HIV testing more generally. Coupled with the findings of the first paper, it seemed 
likely that HIVST could be implemented and would be acceptable to a range of MSM, although 
questions remained regarding feasibility of delivery and acceptability for those who used HIVST, 
especially surrounding ease of use.  
Sufficient information had been captured within these studies, and a further key informant interview 
study I conducted around the same time (the results of which are available in appendix 5) (125), to 
design the intervention for use in SELPHI. This was collaboratively developed with the clinical trials 
unit, with intervention components being selected based on their relationships with acceptability in 
the formative work, and because of pragmatic concerns related to trial design. The two-week follow-
up was included as a response to concerns about lack of support identified in this formative 
research, as was signposting for Terence Higgins Trust (THT) direct, a voluntary sector run helpline 
covering the whole of the UK. These supportive concerns were related to care for self-testers with 
positive results and those with additional sexual health needs identified in this formative study. 
In order to better illustrate pathways to impact in the two SELPHI interventions, I produced a logic 
model at this stage. 
The logic model for SELPHI draw from the first two formative studies (the focus groups discussion 
study, the key informant interviews), as well as another study I led. This third study was a systematic 
literature map, which in itself was a collaborative project with the WHO, in which we began to 
capture emerging literature about HIVST acceptability, feasibility and RCT outcomes (protocol 
available in appendix 1, outputs available at HIVST.org) (31). 
Focus group discussions, in-depth interviews and key results from the map provided themes which 
were mapped onto a framework informed by COM-B. Because SELPHI is an RCT situated within a 
supportive policy environment, the framework focused on producing behavioural alterations 
through the intervention functions specified in COM-B (Tables 4 and 5).  
Contextual factors which I hypothesised to impact on intervention delivery included a cultural norm 
for regular testing; perceived issues with capability and concerns about supportive structures. The 
main testing barriers identified in formative work which HIVST could effectively respond to were 
motivation (reflective & automatic) and opportunity (physical & social). The intervention was 
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conceptualised as inducing changes in these areas, while minimising concerns around capability 
(psychological & physical), which presented the primary barrier to intervention implementation.  
The first intervention (intervention A (figure 3)) is linear, moving from targeted recruitment to a risk 
assessment represented by behavioural questions in a survey, then to receipt and use of the HIVST, 
and lastly a two-week follow-up survey. The advertisement was classified as a form of education and 
persuasion, seeking to enhance motivation (reflective). The risk assessment was a form of 
persuasion, enhancing motivation (reflective) by increasing feelings of vulnerability to HIV. Kit 
provision was a form of enablement increasing opportunity (physical). The two-week follow-up was 
a form of enablement, increasing motivation domains (reflective & automatic) (126, 127). 
Intervention B (figure 4) includes all elements of A, with additional cyclical components consisting of 
a testing reminder and a linked risk assessment delivered every three months which triggers delivery 
of a new HIVST and another two-week follow-up survey. The testing reminder and linked risk 
assessment were forms of persuasion, targeting motivation (reflective & automatic).  
Table 5: COM-B domains and intervention functions (Michie et al 2011) 
Table 4: COM-B intervention types (Michie et al 2011). 
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 The logic model (figure 5) articulates intermediate outcomes assumed to be precursors to achieving 
the trial outcomes. Each intermediate outcome relates to a documented deficit or need constraining 
testing within the target population and which intervention design has been attentive to as a key 
area which requires change. They are described as an outcome (e.g. increased motivation to 
establish HIV status) and a COM-B linked domain which required alteration to achieve this (e.g. 
motivation (automatic)).  
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Figure 5: Logic model for SELPHI interventions 
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3.2 Implementation research 
This phase of my thesis covers implementation research and contributes paper 3, the next in this 
inquiry.  
Following the successful completion of the formative work, the intervention design and logic model 
articulation process, implementation proceeded as planned with a pilot of the RCT during which we 
recruited 10% of the overall 10,000 sample. I had a central role in planning this, with the majority of 
the intervention messages designed by me with input from our participant and public involvement 
representatives. I also designed the recruitment strategy with the trial manager, the emails which 
linked to the various surveys and much of the process evaluation questions in the survey itself. The 
published protocol which details these can be found at Gabriel et al 2018 (92).  
Feasibility and acceptability of the intervention were still central considerations. Although pilot 
projects had delivered HIVST in the UK at this stage, it was still unclear how our specific intervention 
would be received. These pilot projects also reported relatively limited data, especially regarding 
usability, a central question given the capability issues I identified in formative work. In addition, 
there remained no European evidence from people who had used HIVST and capability concerns had 
emerged as a major barrier in the formative work.  
Although quantitative driven questions regarding intervention experiences were included, we 
decided to conduct 15 interviews with a cross section of those randomised to receive a kit in order 
to assess how individuals responded to the technology (topic guide in appendix 6). I found a 
relatively high degree of homogeneity in qualitative accounts in this study. Data saturation was 
reached promptly with these early questions, and I decided to stop interviews after 10 participants. 
This enabled an analysis attentive to how to expand the topic guide to include other domains in a 
further qualitative enquiry (papers 4 & 5).  
I proceeded with the analysis presented in the following chapter in order to identify any alterations 
that were required with the RCT before full implementation. This paper is useful for those seeking to 




3.2.1 Paper 3: Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in 
















































3.3 Evaluative phase 
Following the analyses conducted for in paper 3, it was clear that HIVST implementation was feasible 
and that the intervention was acceptable and usable for a range of MSM. Full trial implementation 
proceeded as planned, and the RCT recruited its full sample of 10,135 MSM and trans people in 13 
months. However, additional questions about HIVST experiences remained relevant for both the trial 
and for the HIVST literature more broadly.  
Although it was clear the intervention was acceptable, the large sample recruited across England and 
Wales provided the opportunity to further investigate the dimensions of acceptability and 
qualitative outcomes for trial participants. While there were key issues emerging with the lancet and 
blood draw (outlined in paper 3), the experiences of a wider range of individuals was important to 
ensure no additional areas would pose a challenge to future use. Experiences of adverse events had 
not been captured, and we had no evidence regarding how people perceived repeated HIVST use, as 
provided in intervention B. This was felt to be a key piece of evidence supporting how HIVST could 
be implemented after SELPHI. This underlined the importance of a qualitative evaluative phase in 
which we could seek additional nuances regarding these key questions.  
 In order to do this, I expanded the topic guide used in the 10 initial interviews in the pilot phase to 
collect data on a broader range of topics (updated topic guide in appendix 7). Deeper 
understandings of experiences of using the kit was required, so I expanded focus in this second part 
of the study to look more closely at issues with the technology itself and included a kit 
demonstration to serve as a reminder of the testing process. In order to add context to many of the 
domains of enquiry which will be answered in the RCT, I included in-depth explorations of HIVST 
impact on STI testing, and looked closely at support needs and the experiences of those with a 
positive HIVST result. This topic guide exactly mirrored participants’ accounts of their journeys 
through the SELPHI intervention, providing a rich dataset exploring key issues with each component 
in the sequence they first encountered them. 
Recognising that local context will shape use, interviews were conducted in a range of geographical 
areas across both countries. Interviews were conducted face-to-face and remotely. For interviews 
outside London I used a mix of audio and video calling, with the latter being used for the kit 
demonstration section. I also travelled to Cardiff and Newcastle to conduct clusters of interviews 
face-to-face with MSM in those cities. 
It was an aspiration of mine to test the coherence of the BCW and COM-B in relation to HIVST 
interventions, but at this stage it was not clear how I might do this. This analysis took shape largely 
by chance, as I outline later. 
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In total I conducted an additional 27 interviews during this phase of data generation. This sample 
was combined with the sample from the pilot for a total of 37 interviews in MSM who had received 





3.4.1 Paper 4: HIV self-testing intervention experiences and kit usability: results from a qualitative 




































Following this analysis, which again found high intervention acceptability, it became clear that 
groups of participants had highly divergent experiences of the intervention. These first emerged 
when looking closely at the role of emotion in HIVST; groups of MSM had quite different emotional 
responses to the technology based on their testing histories and their motivations for engaging with 
SELPHI. I felt that these might be amenable to further exploration and perhaps a useful tool through 
which to gain an understanding of the way the intervention functioned for specific groups. I 
developed a typology of self-testers using these organising principles. How I would use this typology 
remained unclear at this stage.  
After completing the 35th interview in this sample I was invited to present the SELPHI logic model at 
a symposia session at AIDS 2018. I instead proposed presenting a yet to be performed analysis, 
testing the logic model with the groups I had identified earlier as I was concerned the logic model 
presentation would be insufficiently engaging. This led me to conduct a preliminary version of the 
analysis presented in the next paper. While I initially thought it would be relatively inconsequential, 
the intervention experiences between the three different groups were so unique that I felt it was 
worth a more in-depth exploration. This also met an aspiration of the process evaluation embedded 
within SELPHI to identify differences in intervention reception and experience across participants.  
The expanded analysis clarified that these data had the potential to expand the way we think about 
HIVST interventions specifically, but also the way that we think about COM-B and the contexts in 
which it is useful.   
To my knowledge this is a relatively novel way of conducting a framework analysis, using the 
approach for a purpose it was not initially designed for. As such, the analysis approach is itself 
experimental. Never-the-less, the insights gleaned from it are unique in the literature and may have 












3.4.2 Paper 5: Demonstrating pathways to impact: using a testing typology to understand intervention 






























































In this section I first discuss my own position in relation to the topic matter before moving on to the 
ways in which the aim and objectives of this thesis have been met. I then discuss potential logic 
model adaptations which could be made to facilitate future intervention implementation. Following, 
I propose a framework for HIVST implementation in the UK before discussing the merits of COM-B as 
illuminated by this research. Finally, I address the strengths and limitations of this thesis before my 
concluding comments.  
4.1 Reflexivity 
I have a long history with HIVST. When I initially relocated from Brighton to London in 2011 following 
my first degree I was employed at a large HIV voluntary sector organisation. During that time I 
specialised in supporting MSM newly diagnosed with HIV. Although I had a strong background in HIV 
health promotion, I learned much about HIV treatment and transmission. I began to find attending 
sexual health clinics as a gay man extremely cumbersome; the support available was not what I 
needed or what I valued in a clinical interaction.  
Rather than attend clinic appointments, I began to use Insti point of care HIV RDTs to test myself at 
home. I continued testing regularly this way until I enrolled in the PROUD study and started receiving 
regular HIV tests through clinic visits.  
For me, HIVST was a useful way to manage my HIV risk, and to make decisions about my health 
without needing input from other healthcare providers. Never-the-less I remained sceptical about 
the introduction of self-testing; my needs were related to having too much information and I 
worried about men like the ones I saw regularly during my years of self-testing who struggled with 
their diagnoses, oftentimes in isolation.   
I can identify these concerns in my earlier works included in this thesis. The interpretation of these 
data is more cautious than I would likely be now, although they are an accurate reflection of what I 
found and the time period in which they were collected. If I were to repeat the formative study, I 
would have likely been more attentive to the voices in the data who were very supportive of HIVST 
implementation, especially for MSM who would use HIVST to test in response to risk because of 
significant barriers to healthcare settings described in paper 2. Although a minority in the focus 
group discussions, these men did have pronounced utility for HIVST which I could have more fully 
described.  
My perspective and conviction that HIVST is an exceptionally useful tool for many MSM comes from 
the implementation and evaluation studies. I interviewed many individuals for whom HIVST had a 
profound impact on their lives. Because of my role in establishing the RCT and in assisting with 
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implementation, I was often quite touched during these interviews. Although I have made every 
effort to be objective about self-testing in the interpretation of these data, especially in highlighting 
issues with the technology, it is likely that my shift in perspective about the utility of HIVST is evident 
during the shift from formative to implementation and evaluative research.  
4.2 Meeting thesis aims and objectives  
4.2.1 Aim: To develop an understanding of the potential contribution of HIVST to the well-being of 
MSM in England & Wales. 
The overarching aim of this thesis is to develop an understanding of the potential contribution of 
HIVST to the well-being of MSM in England & Wales. Based on the constituent studies in my thesis 
HIVST clearly has a potentially significant contribution in this regard, especially when considering 
intervention adaptations that can be used to broaden testing access for the various groups I identify. 
In this section I describe how I have met each objective of this thesis, which collectively contribute to 
meeting the overarching aim.  
4.2.2 Objective i. To examine the values and preferences of MSM for HIVST interventions considering 
key domains of intervention design. 
The first objective of this thesis is met in the first paper HIV Self-Testing among Men Who Have Sex 
with Men (MSM) in the UK: A Qualitative Study of Barriers and Facilitators, Intervention Preferences 
and Perceived Impacts study which begins this body of work. For the purpose of this objective, the 
key domains of intervention design are test type (including test generation and sampling approach), 
delivery method, instructions and support tools.  
This paper clearly demonstrates the range of preferences relating to HIVST designs and kit types that 
exist amongst MSM in England, and the reasons underpinning them. Perhaps most importantly, a 
strong preference for 4th generation testing was found, as tests with this window period most closely 
match what is routinely available in clinical settings and has the shortest time between initial 
infection and detection. This is despite the current lack of availability of a 4th gen HIVST, perhaps 
constraining potential intervention implementation, and possibly relegating the technology to use 
when no significant recent risk is perceived for many. 
The importance of sample type in decision making is also demonstrated in this publication. Although 
a preference for blood based testing was observed because of higher perceived accuracy, a 
significant minority had a strong preference for oral fluid testing because of their aversion to 




MSM tended to prefer HIVST interventions which delivered kits through the postal system. These 
were perceived to be exceptionally convenient for most and were generally unproblematic, 
providing packaging was discreet and the kit could fit through a standard letterbox. There was a 
minority of MSM who would not access such an intervention however, mainly due to domestic 
privacy concerns. This formative research indicated that this would likely be especially problematic 
for younger MSM who may live in their family home, shared accommodation or with carers, as well 
as Asian MSM who were described by other Asian MSM in our study as more likely to be living with 
female partners or in extended family groups.  
Instructions that were simple to understand and relied on small volumes of text were preferred. In 
this study the kits which were shown to participants were disliked as their relatively opaque 
instructions gave the impression that the tests were significantly more challenging to perform than 
they were. Video instructions were also valued.  
In terms of support, interventions which provided helplines were felt to be essential in order to 
mitigate against potential harm and to support correct use. Further results drawn from papers 3 and 
4 demonstrate the importance and value of follow-up systems embedded in the intervention, 
especially those that record results through follow-up approaches and can signpost to care if 
necessary. This type of support tool mimics what has been implemented with MSM in the UK and in 
other high-income settings (128-130).  
This first paper demonstrated the variability in preferences for HIVST interventions and illuminates a 
core benefit of the approach: HIVST interventions can be tailored to the preferences of the groups 
being targeted by service delivery. Doing so allows for more responsive interventions enabling wider 
uptake than one intervention approach might facilitate, especially when compared to clinical 
interventions which may be constrained by clinic spaces and priorities, with the needs of 
beneficiaries often being secondary considerations. This illustrates the contribution HIVST can have 
to the well-being of MSM in England and Wales by providing an additional, flexible intervention 
which better meets need across heterogenous groups.  
4.2.3 Objective ii. To explore the potential barriers and facilitators of HIVST for MSM using COM-B as a 
framework. 
The first paper from the initial formative study also addresses the second objective of my thesis. This 
publication explores the primary barriers and facilitators that potential intervention beneficiaries 
face when considering uptake, described using COM-B. Capability, both physical and psychological, 
were largely associated with barriers such as difficulty performing the test. Opportunity and 
motivation had both associated facilitators and barriers.   
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When considering potential HIVST interventions, concerns around capability (physical) were a 
significant issue for MSM. This was due to the instructions in the existing kits in the first formative 
study, but also because of concerns regarding their own abilities in operating an RDT properly, and 
the potential risks associated with failure, such as an incorrect result. This is in line with existing 
literature, although perhaps more pronounced (62, 80). 
Capability (psychological) was typically seen to be reduced by the dislocation of testing from care 
pathways, because of concerns around the implications of receiving a positive result alone, the 
potential for social harm and the perceived likelihood that HIVST would reduce STI screening. 
However, this domain was enhanced for those with significant privacy concerns (largely those who 
tested sub-optimally) by the added confidentiality provided by HIVST interventions, giving 
beneficiaries a level of privacy not typically provided in clinic based interventions. This could 
however be partially eroded depending on delivery mode as discussed previously.  
Opportunity (physical) was shown to be enhanced by the provision of HIVST through increased 
choice offered by the potential of HIVST interventions, and the range of alterations that could be 
made for individual target groups. Strong testing norms (as illuminated in the second paper of this 
thesis), provide a facilitator to HIVST uptake, working through opportunity (social).  
Motivation (automatic) was enhanced through the additional convenience associated with HIVST; 
reduced opportunity cost provided a strong incentive to access a novel intervention. Participants’ 
motivation was also reduced however by the potential for HIVST to reduce STI testing frequency, 
posing a danger to both self and community by potentially increased incidence of STIs, underlining 
the importance of developing strategies to respond to this concern.  
Motivation (reflective) was reduced by concerns about HIVST’s dislocation from established care 
pathways, providing a barrier to uptake. This is a well documented concern with HIVST (32, 40, 52, 
75). Reflective motivation could also be influenced by sample type, window period and support tools 
provided; different options could pose either a barrier or facilitator to uptake depending on 
intervention design and the preferences of the end user.  
Individuals planning and implementing testing interventions need to take into account a variety of 
barriers and facilitators specific to HIVST. This provides a good starting point in terms of evidence 
elucidating what these are, how they might be operationalised and the COM-B channels through 
which they function. This demonstrates the barriers that must be overcome and facilitators 
harnessed to enable appropriate service provision of HIVST thus potentially enhancing the well-
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being of MSM in England and Wales. To my knowledge this is the first inquiry into HIVST that uses 
COM-B in this way.  
4.2.4 Objective iii. To understand how HIVST compliments existing testing strategies considered or 
adopted by MSM. 
This objective is met through the second paper from the formative focus group discussion study. 
This manuscript explores the normative understandings of the predominant testing motivations for 
MSM, providing insights into the ways HIVST may be received upon implementation. This is a 
significant contribution to the academic literature as prior to this research it was unclear the role 
that self-testing may fill and what considerations implementation had to be attentive to.  
This study found three clear motivations for accessing testing: in response to risk; for reassurance, 
and out of routine. Testing in response to risk was a normative practice, and was understood 
universally as a primary testing motivation. Given issues regarding a perceived lack of support for a 
potentially reactive result, HIVST was not thought to be useful for testing in this context except 
where significant barriers to clinic access existed.  
Testing for reassurance was a major theme, especially for those in the general focus group 
discussions and those with MSM at higher risk of HIV acquisition. When considering testing in 
response to this motivation, MSM were seeking confirmation of a continued HIV negative result, 
rather than because they felt there was a possibility of infection. Never-the-less, the anxiety driving 
these testing motivations was significant and could be challenging to manage. HIV testing was felt to 
be a form of self-monitoring and risk management in this context. In these narratives, HIVST was 
perceived as a useful self-management tool, ‘topping-up’ between clinic run tests and providing 
reassurance of a negative status.   
Frequent HIV testing was strongly viewed as a normative behaviour for many MSM in this study, 
reflecting wider research (20). These norms were a palimpsest with layers drawn primarily from 
friends and peers, with health promotion practitioners, those working in clinical services and public 
health agencies contributing to their increasing emphasis and reinforcement over years. Testing 
norms were so widely held that MSM who had never tested for HIV struggled to disclose this in focus 
group discussions. HIVST was felt to be exceptionally useful in narratives surrounding testing in 
response to biomedical norms disseminated through friends and peers, as the technology allowed 
individuals to meet these expectations with limited effort. However, for some, self-testing 
transgressed other norms by bringing HIV testing into the home.  
These results indicate ways in which HIVST complements existing testing strategies adopted and 
considered by MSM, illuminating the likely reception the intervention will receive and its position 
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alongside other services. Based on these narratives, self-testing will likely be confined to testing 
when not perceived to be at significant risk of a positive results, except for when major barriers to 
clinic access exist. Implementers can therefore consider the various needs of different populations; 
those who test in response to risk will likely maintain their clinical barriers whatever the result and 
supportive structures clearly must consider this issue in intervention development. This 
demonstrates the potential of HIVST to contribute to the well-being of MSM in England and Wales 
by reducing opportunity costs when testing for reassurance and out of routine, and by providing a 
testing mechanism for those who seek testing in response to sexual risk, but who have significant 
barriers to clinic access.  Although motivations and testing norms around HIV testing generally are 
well understood in the literature (20, 131), this is the first publication that explores this in such 
depth in the context of HIVST.  
4.2.5 Objective iv. To assess the feasibility of recruiting MSM to the SELPHI pilot, and the acceptability 
of the HIVST intervention used among those randomised to receive a kit. 
This objective is addressed through paper 3 of this thesis, drawn from the study that provides a link 
from formative to implementation research. Recruiting MSM to the pilot was demonstrated to be 
feasible, and the intervention highly acceptable among those who received it. This provides the first 
European data about usability of HIVST amongst end users, providing a vital piece of evidence to 
support implementation efforts.  
In this study I demonstrate the feasibility of recruiting a broadly representative sample of MSM to 
the RCT pilot using a range of platforms, as outlined in the comparison with other convenience and 
probability based samples (126). In contrast with Vera et al 2019 (68), this publication demonstrates 
HIVST can reach significant numbers of MSM who do not test in line with national guidelines. In 
contrast to Gibson et al 2016, this study had much higher retention with vastly more participants 
completing the two-week and three-month surveys (69).  
These results also highlight the need to design interventions which require minimal steps between 
them. In the pilot phase, 25% of participants did not link through from the recruitment to enrolment 
surveys, leading to attrition at this stage likely due to the demands of trial processes.  For 
interventions distributing free kits very widely in a routine setting, simplicity of access should be a 
key goal.  
I found that HIVST outperforms HIVSS tests on test completion when comparing our results to self-
sampling service evaluations. In total, 95% of those who filled in the three month survey in the pilot, 
far outperforming the 55% return rates of HIVSS (126).  
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Test kit usability was extremely high in this study, with the vast majority reporting good or very good 
experiences, higher than in many other studies. This was not expected given the capability concerns 
identified in the formative work (27), although extensive efforts went into addressing these before 
the pilot phase of the RCT. Never-the-less, elements of the kit such as the lancet and the buffer pot, 
both sources of usability problems, could not be changed leading to concerns that capability issues 
may persist.  
The findings of this usability analysis are further nuanced by the qualitative data, which 
demonstrates that despite very high usability, capability issues did indeed remain especially in 
relation the use of the spring loaded lancet to draw blood, a step which was felt to be challenging by 
some. The instructions were perceived to be easy to understand, perhaps reflecting increased 
simplicity introduced following a kit redesign by the manufacturer which also reduced the size of the 
box so that the kit could fit through a standard letterbox. Opportunity was enhanced by the 
provision of a free HIVST, ameliorating barriers pertaining to inconvenient clinics, and psychosocial 
barriers such as privacy and stigma. Motivation (reflective & automatic) was negatively affected by 
increased anxiety associated with the intervention as a whole, and the 15-minute waiting period for 
results.  
This significant contribution clearly demonstrates that intervention delivery is feasible, and the kit 
usable. Some issues surrounding capability remain, although they are less pronounced than might 
have been predicted following the formative work. Self-testing clearly ameliorates barriers to testing 
access, but poses its own challenges with regard to a potential increase in anxiety amongst some 
end users. This demonstrates that HIVST contributes to the well-being of some MSM in England and 
Wales by providing a convenient, highly acceptable HIV testing method which leads to increased test 
completion when compared to HIVSS, thus lessening missed testing opportunities and potentially 
reducing undiagnosed HIV.  
4.2.6 Objective v. To explore the experience of utilising HIV self-tests and the implications for further 
intervention development and scale-up. 
The fifth objective of my thesis is met by the fourth paper which itself is drawn from a study 
investigating intervention experiences among cis-gender MSM in the SELPHI RCT, the third 
constituent study of this thesis. In this publication I use in-depth interviews to explore the 
experiences of 37 MSM who participated in SELPHI. This is the first purely qualitative evidence 
investigating HIVST experiences of use from Europe. This study provides important insights into the 
experiences of different groups of MSM, based primarily on previous testing history and makes a 
significant contribution to the literature, especially in relation to the role of emotional responses in 
HIVST acceptability and uptake.  
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MSM were motivated to access the intervention because of a reduction of barriers related to stigma 
from clinic staff and attendees, as well as simultaneous increases in privacy and in convenience. 
HIVST was conceived of as generating either more or less anxiety than other services based primarily 
on testing history and motivation for testing; individuals who were less testing experienced and 
those testing in response to risk reported increases in anxiety relative to other testing methods. 
There was a significant minority, however, who felt HIVST reduced anxiety associated with other 
testing services by placing them at the centre of their decision making around their health.  
In this paper I also described how the supportive components of the intervention worked to 
facilitate increased engagement with testing more broadly by providing a series of reflective 
experiences throughout the intervention process. This provided a sense of involvement with and 
connection to the trial, and facilitated increases in motivation to test generally.  
Although the support structures were felt to be adequate and in line with expectations, most in this 
study sought support (regarding positive and negative results) from wider social groups. This 
includes both of the participants with positive results who initially told a friend or a family member 
before seeking care. This underlines that HIVST is a socially embedded testing technology, expanding 
healthcare into the private realm.  
Capability concerns were again a significant theme within this analysis. Although most completed 
the test without errors, several participants had difficulty with both the blood draw and test 
processing stage. Two broke their first HIVST test stick while attempting to use it, underlining the 
role of enhanced supportive information and instructions accompanying these tests.  
The 15-minute waiting period between the test processing stage and result interpretation stage 
were described universally as an exceptionally anxious period. In this period of vulnerability 
individuals had intense reflection on their potential risks, often concerns which were not grounded 
in reality as many had no significant risk of which to speak.   
I describe important qualitative outcomes relevant to implementation. Firstly, individuals who had 
higher barriers to clinic access based on stigma, privacy concerns or geographic issues tended to 
describe HIVST as facilitating increased testing frequency, but with the potential to reduce STI 
screening by reducing incentives to access clinical services. Secondly, minor adverse outcomes (n=2; 
fainting, relationship discord) were also reported by two individuals, a key finding given that I did not 
sample based on this criteria and the adverse outcomes were discovered spontaneously. Although 
these did not affect intervention acceptability, intervention development should be attentive to 
concerns regarding potential adverse outcomes. Finally, both individuals who had positive HIVST 
139 
 
results linked to confirmatory care within 24 hours and described very high intervention 
acceptability, crediting the technology with saving their lives.  
Clearly this study illustrates a variety of considerations for intervention development and scale up. 
The role of emotion in HIVST needs to be accounted for in developing interventions which provide 
reassurance where possible. This could be done through a variety of mechanisms, including 
enhanced access to counselling, reassuring messaging about HIV treatment, prompts to discuss 
difficulties with family members and other social contacts as appropriate, and linkages to other 
types of support both online and face-to-face. Capability concerns continue to be an issue for those 
operating the tests, underlining the need for clear instructions and more prominent linkage to 
alternative forms of instruction such as videos. Bacterial STI self-sampling for STIs should also be 
considered for inclusion in self-testing packages of care in order to counteract concerns regarding 
reduced uptake of STI testing.  
This provides strong evidence that HIVST can improve the well-being of MSM in England and Wales 
by providing a highly acceptable testing intervention which addresses previously identified issues 
surrounding care pathways and, to an extent, capability issues while increasing choice and 
facilitating more frequent testing among some MSM who test sub optimally. The potential of HIVST 
to place those with concerns about healthcare access at the centre of their decision making around 
testing is a significant benefit, perhaps transforming how these men access services.  
4.2.7 Objective vi. To explore how components of the SELPHI interventions impact on 
behaviour for, and are experienced by, RCT participants. 
The sixth objective of my thesis is met in the fifth paper included. This is drawn from the third study 
investigating intervention acceptability and experiences of cis-gender MSM in the SELPHI RCT. This 
study uses an innovative method to investigate the experiences of distinct groups of MSM identified 
in the data. During analysis it was clear to me that there were three distinct groups with profoundly 
differing intervention experiences. I formalised these into an inductive typology based largely on HIV 
testing history and engagement with SELPHI. I then used these as the lynchpin for a framework 
analysis investigating to what degree the assumed intermediate outcomes related to specific 
intervention components were experienced by these groups, and to investigate reasons for 
variations within these. This analysis demonstrated the mechanisms through which HIVST can 
contribute to well-being among MSM in England and Wales.  
The three groups identified were ‘inexperienced testers’; ‘pro self-testers’ and ‘opportunistic 
adopters.’ Inexperienced testers were those who had little or no testing history and did not test out 
of routine; they were typically early in their sexual or testing careers and tended not to be very open 
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about their sexual orientation or practice. They had high psychosocial barriers to testing relating to 
the COM-B domains of motivation (reflective & automatic), opportunity (social & physical) and 
capability (psychological). These barriers included lack of risk perception, shame, fear of stigma, 
privacy concerns and low self-efficacy when considering testing in a clinic. Some also had concerns 
related to the COM-B domain of opportunity (physical) (e.g. inconvenient clinics). HIVST ameliorated 
many of these concerns, facilitating testing uptake.  
Pro self-testers were often at an intermediate point in the sexual careers and sometimes lived partly 
hidden lives in terms of their sexual orientation. Men in this group had many of the same 
psychosocial concerns related to opportunity (social & physical) and capability (psychological). This 
group tended to have a testing history and were somewhat motivated to access testing, but their 
frequency was constrained by the high barriers to clinic access they faced. HIVST was the most 
preferred testing method for this group as it ameliorated many of their psychosocial and 
opportunity (physical) concerns, facilitating increased testing frequency.  
Opportunistic adopters were men who are well served by existing testing opportunities with few 
distinct COM-B barriers, except for some minor issues with opportunity (physical). Some in this 
group used HIVST because of increased convenience, but the majority engaged with the intervention 
out of novelty and to respond to social norms around testing. 
Assumed intermediate outcomes were highly variable across groups. Figure 6 provides an overview 
of the differences in these based on strength of qualitative evidence. The intermediate outcomes 
assumed in the SELPHI logic model were most closely matched for the first group amongst whom 
there was typically strong evidence of intermediate intervention outcomes. For men in this group, 
HIVST engaged them in testing more generally through a variety of intervention components. The 
adverts increased motivation (automatic), and kit provision strongly enhanced opportunity (social) 
by providing an additional, private testing method while also increasing opportunity (physical). The 
two-week survey increased motivation (reflective) by providing a reflective experience which 
increased engagement with testing generally. There was some evidence that the risk assessment 
embedded in the intervention increased risk perception through motivation (automatic) channels, 
but this was partial.  
For pro self-testers, evidence began to diverge. Kit provision did increase privacy and therefore 
opportunity (social), as well as physical accessibility, and the testing reminder increased engagement 
with testing through motivation (reflective) channels. There was however only partial evidence 
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regarding the adverts and two-week survey increasing motivation, as this group was already largely 
motivated to test. There was weak evidence that the surveys increased risk perception.  
Opportunistic adopters had the highest divergence in experience from the logic model. For this 
group the provision of the test increased convenience through opportunity (physical) channels and 
the testing reminder increased engagement with testing. However, there was less evidence 
regarding increases in testing motivation relating to the adverts and weak evidence on the rest of 
the assumed outcomes.  
This demonstrates the clear differences various groups of MSM have when engaging in the HIVST 
intervention provided by SELPHI. Clearly experience is highly variable across groups, and largely 
related to the COM-B domains individuals have barriers around. These findings allow a close 
examination of intervention functions which facilitates a reimagining and redesigning of HIVST 
interventions to better meet the needs of heterogeneous groups of MSM, facilitating responsive 
interventions which can contribute to increases in well-being by improving interventions, their 
targeting and their delivery. This study is not only methodologically unique, no other research in the 
existing literature investigates HIVST experiences in this way amongst intervention beneficiaries.  
4.2.8 Objective vii. To examine the utility of COM-B as a useful model for understanding behaviour 
change in relation to the provision of HIVST. 
This objective is also met in the fifth paper of my thesis. Using a novel application of framework 
analysis has enabled me to demonstrate the ways the intervention functioned for groups with 
distinct differences in COM-B deficits. This illuminates the utility of COM-B as a model for 
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understanding behaviour change in relation to HIVST provision, and the challenges in using it for this 
purpose.  
As it is currently articulated, COM-B makes no differentiation about the utility and impact of 
intervention components for those with pronounced needs for an intervention versus those who 
engage for other reasons (91). Clearly, for those who engaged with the SELPHI intervention, 
assumed outcomes from our logic model were only achieved in those who had distinct deficits in 
these areas. Further, it seems that the strength of outcome experienced may have been related to 
the level of barrier. This demonstrates that interventions only function as intended for those who 
have specific areas of need which the interventions respond to. Interventions are often designed for 
those with the highest deficits, potentially involving components which beneficiaries find irrelevant 
at best, or cumbersome and annoying at worst. It also shows that in COM-B the intervention 
functions described only enact changes in the individual under certain conditions. This is a significant 
departure for how COM-B is thought about as currently it is presented as a monolith: all things in it 
are presented as true in all circumstances.  
This paper therefore illustrates that although COM-B can be useful for conceptualising interventions 
and how they function, it does not take adequate account of the implications of delivering 
interventions to those who do not have the hypothesised COM-B deficits. The potential for 
frustrating beneficiaries and providing components they do not value may have the converse impact 
of reducing acceptability through needless components. It does however illustrate the importance of 
designing flexible interventions which account for a range of needs. Harnessing this knowledge for 
HIVST and other multi-component interventions delivering new prevention technologies can 
contribute to the well-being of MSM by providing flexible, acceptable interventions which better 
meet their needs.   
4.3 Logic model adaptations 
Over time, as I have developed this evidence base on HIVST, my thinking on how interventions work 
for individuals has evolved from my initial logic model theorising. This has necessitated adaptations 
in the SELPHI logic model to reflect the understandings that have emerged from the third, fourth and 
fifth paper of my thesis. Specifically, I suggest an additional level of outcomes and expanded detail 
on context. Instead of moving from intervention processes to intermediate outcomes and then on to 
trial outcomes, I have shifted what I previously conceived of as intermediate outcomes to the 
immediate level, and have developed a range of intermediate outcomes which occur before, and 
facilitate, trial outcomes which have been renamed long-term outcomes. I also more clearly specify 
the groups who are likely to experience these outcomes based on their COM-B deficits. I included 
additional detail on context, reflecting the structural and political changes that have occurred over 
143 
 
this research period and which influence the intervention. Figure 7 presents the updated logic 
model.  
4.3.1 Context 
Strong cultural norms for HIV testing support HIVST uptake, with constraints drawn from perceived 
issues with capability and a lack of supportive structures. It is also clear that well-documented 
healthcare rationalisation and the closure of sexual health services will create barriers to existing 
services which will also increase HIVST adoption. This should not be seen as a positive development, 
but is clearly important in considering intervention uptake as it could potentially change the context 
of use for those who access the intervention. Indeed, there may be increased engagement from 
groups who have an HIV testing routine and are testing in response to risk, whose first preference 
would be to access a bricks and mortar service but who face new structural barriers to access. In 
addition, increased focus on self-management in healthcare may shift norms around testing, 
overcoming issues related to the incursion of HIV testing into the domestic sphere (58).  
4.3.2 Immediate outcomes 
These outcomes have been brought forward from the intermediate outcome level acknowledging 
that these occur almost immediately at the point of contact with the intervention components. It is 
clear that these are not evenly distributed amongst those accessing the interventions: for those who 
are new to testing or have high psychosocial barriers to testing access, the intervention performs 
most closely to the assumptions specified in the logic model. For those with more testing experience 
and limited barriers to access, many of the intervention functions have little impact. I have removed 
that the risk assessment increases motivation to test as evidence in this regard was non-existent in 
most groups and scant even in inexperienced testers.  
4.3.3 Intermediate outcomes 
I have developed additional hypothesised intermediate outcomes which are necessary pre-
conditions to achieving the trial outcomes and which follow from the immediate outcomes. These 
reflect the changes in how I conceptualise the ways in which HIVST interventions function, drawing 
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Figure 7:  Updated logic model 
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These are: 1) HIVST increases engagement with HIV testing more broadly (motivation: automatic); 2) 
HIVST provide a bridge to clinical services including HIV and STI testing, as well as to other new 
prevention technologies (capability: psychological); 3) HIVST use builds confidence and skills in 
performing self-administered HIV tests (capability: physical). 
Given the transformation observed for inexperienced testers in the 5th paper of the thesis, it is clear 
that HIVST interventions can fulfil the dual role of engaging individuals with both HIV testing more 
broadly and with other clinical services. This is enacted through several processes. Firstly, barriers 
related to fear regarding the outcome of a positive test are reduced by those without testing history 
and who use an HIVST and receive a negative result, eliminating a key barrier to service access. 
Secondly, familiarity with the process of testing, coupled with the supportive elements of the 
intervention, increase engagement with testing through a series of reflective experiences which 
occur at different times throughout the intervention journey. Finally, by reducing barriers to testing 
generally, barriers to other services are also reduced through increased comfort and feelings of 
capability in service access.  
Another important intermediate outcome is that HIVST exposure increases capability for those who 
access the intervention. Despite this area being a major concern for those engaging, having used a 
self-test makes it much more straightforward to operate one in the future. Although individuals had 
concerns about operating the HIVST and some issues with the lancet and test processing stage, as 
reported in papers 3 and 4, all felt these would become less problematic over time. Paper 4 provides 
the clearest evidence of this; both participants who broke their kits were able to source 
replacements and complete the test properly.  
4.3.4 Long-term outcomes 
In this logic model I have renamed the final section from trial outcomes to long-term outcomes, 
illustrating that these outcomes are important for public health more widely, rather than just for 
SELPHI. I have included that HIVST contributes to the well-being of MSM through improving service 
access and sexual health as illustrated by the constituent studies of this thesis  
4.4 Intervention implementation: a recommendation and a framework 
On the basis of these findings, I recommend the implementation of free online HIVST in England and 
Wales to support the well-being of MSM and to provide an additional testing option alongside a 
diverse array of service provision. In order for HIVST to fulfil its potential in meeting the needs of 
groups least likely to test and to widely increase testing engagement, the flexibility offered by the 
technology must be harnessed in intervention design. For example, HIVST could be provided through 
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a national programme, perhaps providing specific intervention adaptations in regions and to specific 
sub-populations with unique needs. 
In this section, drawing on the constituent studies of my thesis and the wider published literature, I 
explore potential adaptations to increase the reach, uptake and effective use of self-tests, especially 
among underserved groups. I also describe the key concerns which implementation must be 
attentive to. I draw on the first four of the five broad categories identified in CFIR (first explained in 
section 2.2) to illustrate the main areas of concern in service delivery, mainly the intervention, the 
outer and inner settings and individual characteristics (95). I do not focus on process of 
implementation as this is beyond the scope of this thesis and is dependent on how the intervention 
is commissioned and who is responsible for service delivery (95).  
4.4.1 Core components 
In CFIR, the intervention is divided into two parts: core components and the adaptable periphery 
(95). Core components refer to elements of an intervention which cannot be changed and must play 
a central role in intervention delivery (95). This section describes considerations relevant to the core 
components of HIVST, mainly, the RDT being used.  
Currently no self-tests are available globally which use 4th generation assays which provide the 
shortest window period possible with an RDT, reducing this from 6 weeks to 4 (2). Given the 
preferences for the shortest possible window periods and high sensitivity observed in formative 
work, it is imperative that these are developed in the future in order to more widely meet the needs 
of MSM. These are technically possible; currently 4th generation RDTs exist which could be adapted 
for self-use as has been the case with other tests. This adaptation may have the advantage of 
expanding self-testing to individuals testing following a risk event who are also comfortable 
accessing clinics as identified in the formative papers of my thesis (27, 58). 
Although blood sampling is preferred by many MSM in England and Wales due to its advantages in 
terms of sensitivity, a significant minority of MSM will not access self-testing while only blood-based 
tests exist. Thus, oral fluid self-testing should be considered as a supplementary option to support 
men in testing more frequently and comfortably. Additional attention will be required in 
implementing these as they have more limited utility for MSM on PrEP as the detection of 
seroconversion can be blunted due to the antibody detection assay used and lower sensitivity, 
potentially leading to missed infections (132).  
4.4.2 Adaptable periphery 
This section described the elements of interventions that can be adapted depending on the needs of 
the target population drawing on data from the constituent studies of my thesis. The elements 
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discussed here are presented in table 6, which described the potential intervention approaches, 
their target audience and the COM-B domains associated.  
Capability issues remain a primary barrier to HIVST uptake which is critical to resolve. While 
manufacturer provided kit instructions are sufficient for many MSM, clearly significant capability 
concerns remain, as demonstrated by papers 3 and 4 in this thesis. For some, these can be resolved 
in straightforward ways such as providing supplementary information with the kit, or very clearly 
signposting to freely available videos explaining the testing process and how to interpret the result. 
For those with significant capability challenges (e.g. those with lower educational attainment, non-
English speakers), this will likely be insufficient. Acknowledging the privacy barrier posed to this 
approach, these men may benefit from in person demonstrations from peer support workers or 
healthcare providers depending on the service delivery model. It is also critical that interventions are 
designed so that end users can easily source replacement kits when efforts to conduct an HIVST fail.  
Delivery mode for self-tests is an important consideration to increase accessibility widely by 
improving opportunity (physical & social). For the potential of self-testing to be realised, 
interventions must take into account a range of needs related to this issue. This is especially true 
given the high value many place on privacy in HIVST interventions (2, 27, 32, 82). In order to counter 
domestic privacy concerns, distribution mechanisms whereby individuals can access kits themselves 
without having them sent to their home or another address are required (27). These can be through 
healthcare services such as pharmacies or clinics, or, recognising other potential privacy concerns, 
through automated systems such as click-and-collect functions or through vending machines. As 
previously discussed, the latter has been successfully trialled in Brighton and could potentially be 
expanded to other locations with high densities of MSM and other affected groups (75). It is 
important to note that this demonstration project reached low numbers of MSM who were testing 
sub optimally, perhaps reflecting its location in a sex on premise venue both reaching a group at 
potentially increased risk who were already testing frequently, but also in a location posing 
additional psychosocial barriers to access. Never-the-less this approach may help boost equity in HIV 
testing interventions if placed appropriately, especially by providing a testing opportunity to Asian 
MSM, and younger MSM who are perhaps more likely to have concerns related to domestic privacy 
(27).  
Targeted outreach has been used in other settings to reach MSM at higher risk of HIV acquisition 
and could be an approach which helps increase social acceptability of self-tests and provides 




Table 6: Intervention adaptations, target audiences and COM-B domain 
Intervention component Possible adaptations Target audience COM-B domain 
Test generation  4th generation assay All MSM Motivation (automatic) 
Sample type Blood Most MSM Motivation (automatic) 
Saliva MSM with aversion to blood draw Capability (physical) 
Instructions Providers’ written instructions Most MSM Capability (physical) 
Enhanced written instructions MSM with minor capability needs Capability (physical) 
Video Most MSM Capability (physical) 
Demonstration MSM with pronounced capability needs Capability (physical) 
Delivery mode Postal Most MSM Opportunity (physical) 
Click-and-collect MSM with domestic privacy issues  Opportunity (physical) 
Vending machine MSM with high privacy barriers Opportunity (social); capability (psychological) 
Pharmacy & clinic MSM with capability or support needs Opportunity (physical & social), Capability 
(physical) 
Outreach MSM at higher risk Opportunity (physical), capability (physical & 
social) 
Partner delivered MSM at higher risk Opportunity (physical), capability (social) 
Support Passive reporting and follow-up MSM with lower level needs Motivation (automatic) 
Help line All MSM Motivation (automatic) 
Active follow-up  MSM testing for the first time Capability (physical & psychological) 
Online counselling MSM with high level needs Capability (physical & psychological) 
Demand generation Advertisements All MSM Motivation (automatic), capability (social), 
opportunity (physical & social) 
Risk assessments MSM who test infrequently Motivation (reflective) 
Testing reminders MSM who test sub optimally Motivation (automatic), opportunity (social) 
Accompaniments Bacterial STI self-sampling MSM who test at clinics infrequently Motivation (automatic), capability 
(psychological) 




An option which has been used widely in other settings is to design interventions whereby 
individuals distribute HIVSTs to their sexual partners. This approach has the advantage of potentially 
reaching individuals with the highest levels of concern around privacy and healthcare access, while 
also potentially exposing those distributing kits to unintended outcomes such as harm and 
relationship breakdown (133-135).  
Clearly varying levels of support regarding using an HIVST and in dealing with the psychological 
consequences of testing are required by different groups of MSM. For perhaps the majority, basic 
levels of support will be adequate for their needs. A minimum standard of support should be 
established, and include a results recording follow-up system and a telephone helpline for those 
requiring it. Interventions could then provide active follow-up for those reporting positive results. 
For groups with higher needs (e.g. first-time testers, younger MSM, people with specific learning 
disabilities, individuals with identified language issues) an optional active follow-up system could be 
provided with a healthcare worker contacting individuals identified either through an algorithm 
selecting candidates based on demographic and behavioural characteristics, or through an opt-in 
process. This system would require permission from the end user and could potentially help manage 
or reduce any harms which might occur. Kits have also been developed in the US which include a 
Bluetooth beacon which activates upon opening prompting a counsellor to contact the user, with an 
RCT demonstrating feasibility of service delivery (88, 136). This could be an option provided to the 
same groups as active follow-up could target. Both options would require permission from the end 
user and clear information about the provision of this, lest these intervention types negate benefits 
of privacy and confidentiality associated with HIVST. 
Demand generation initiatives will be required to draw people to the intervention, working through 
motivation channels and through increasing opportunity (social). This will also be helpful in 
increasing uptake as HIVST use spreads from the first groups who access it (innovators, early 
adopters, early majority) into those who pick up the intervention in later phases (late majority and 
laggards) (59). Clearly, as demonstrated by the third paper in my thesis and in other pilot and 
demonstration projects (69, 128, 129), online advertisement is likely to be the cornerstone of self-
testing interventions in England and Wales. Other demand generation initiatives can also be 
considered, such as automated testing reminders, especially for those who report markers of risk 
such as CAI. Broader social marketing initiatives, such as those funded by the statutory sector, could 
incorporate information about HIVST, ideally highlighting facilitators (e.g. convenience, privacy), 
minimising capability barriers while potentially harnessing narratives around uptake including testing 
out of routine (27, 58, 126). Finally, HIVST could be included in broader longitudinal e-health 
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promotion interventions, providing kits to individuals taking part in them as an additional option 
rather than forming the cornerstone of an intervention (137).  
In order to counter the well documented concern about lack of STI testing in HIVST interventions (2, 
27), STI self-sampling kits should be provided boosting acceptability through motivational and 
capability channels. Dual HIV and syphilis STs are currently being developed and may be a key 
development, broadening the utility of self-testing to cover additional STIs.  
4.4.3 Outer setting 
In CFIR, the outer setting is defined as the economic, social and political context that affects 
implementation (95). Generally this is used as a lens through which to view an organisation’s 
position inasmuch as it affects a pathway to implementation. For the purpose of this thesis I use it to 
refer to the broader economic, political and social contexts of service delivery.   
Although few data exist about cost savings with HIVST, the technology has often been promoted as a 
low cost intervention which could potentially be useful for diverting patients from bricks and mortar 
services. HIVST has emerged at a time of austerity, healthcare rationalisation and the associated 
widespread closure of GUM clinics. This may lead to commissioners relying on HIVST as a cost saving 
mechanism, as has been the case with HIVSS. Although this supports intervention implementation, it 
fails to consider that HIVST is, for many, a supplementary testing technology and that it is vital for 
existing services to be maintained to meet the wide variety of needs of heterogeneous groups of 
MSM (15, 58). Implementing organisations must be attentive to this, and resist pressure to 
rationalise services in favour of self-testing.  
This temptation for commissioners to replace clinics with remote approaches such as HIVST 
programmes is perhaps the largest threat to successful implementation. As demonstrated in my 
thesis, HIVST interventions are a supplementary testing option for many MSM who highly value 
interactions with healthcare professionals. Deprioritising clinical interactions has the potential to 
reduce HIV and STI testing amongst many MSM, while also potentially leading to an increase in STIs. 
Service provision must be attentive to these potential issues.  
Current public health priorities also align with widespread implementation. The drive to reduce new 
HIV infections through expansion of testing through the test and treat agenda clearly supports the 
widespread introduction of HIVST, especially given the potential to reach those who test less often 
and increase their testing frequency. HIVSTs wider ability to engage MSM in testing, as 




Culturally, among MSM, strong norms around HIV testing support HIVST implementation. This is 
demonstrated in my thesis by the potential contribution of HIVST to the well-being of MSM through 
its role in testing for reassurance.   
4.4.4 Inner setting  
In CFIR, the inner setting refers to the structural, political and cultural contexts through which 
implementation will proceed (95). For HIVST this mainly means the structural context of potential 
implementing organisations, and the features and priorities of organisations likely to deliver HIVST.  
Structurally, implementation is not necessarily supported by current priorities and attitudes. 
Currently, Public Health England (PHE) commissions the national HIVSS service on behalf of 
participating local authorities in England. This approach was used partly because it retains links with 
the service user to the organisation facilitating follow-up for false positives (a significant issue with 
the technology) (138), and linkage to care for true positives. This approach also has the benefit of 
contributing to surveillance data. For HIVST to be implemented by PHE, a culture shift is required. 
Because HIVST relies on the service user to seek care themselves, potentially with limited support 
from healthcare professionals, PHE may be reluctant to adopt the technology over concerns of sub-
optimal linkage to care when compared to HIVSS approaches. It is vital for HIVST to be implemented 
that patient autonomy is respected and the choice not to seek immediate care following a positive 
result using an HIVST is understood as a socially situated decision grounded in rational decision 
making for some people. The emphasis on capturing all potential positives within surveillance must 
also be relaxed to support the technology. Given that HIVST is likely to outperform HIVSS at scale 
this will mean potentially increasing rates of diagnosis on the whole, while also possibly losing some 
individuals at the first step of the care pathway. In this scenario HIVST will still contribute to an 
overall increase in well-being for MSM in England and Wales however by perhaps diagnosing more 
HIV and reducing service provision barriers.  
The features and priorities of implementing organisations are likely to be supportive; two of the four 
main demonstration projects have been provided by the voluntary sector, namely the Terrence 
Higgins Trust and SH:24 (128, 129). Both of these organisations have experience in developing 
systems to provide a basic level of support and would likely be capable of providing the intervention 
alterations which might be required to increase acceptability and reach.  
4.4.5 Individuals involved 
The fourth domain in CFIR is individuals involved in the implementation process. For implementing 
organisations themselves, delivering HIVST is not a significant departure from the work they 
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currently do. However my previous formative research with key informants in England suggests that 
some may be resistant, especially those in clinical settings (125).  
A robust evidence base should help assuage concerns, however additional motivators may need to 
be put in place to gain buy-in from these groups. Although beyond the scope of my thesis to discuss 
these in-depth, these could include small local needs assessments informing adaptations and 
increasing buy-in, the development of interventions responsive to local needs and a robust evidence 
base demonstrating the benefits of HIVST among their client groups and the potential to expand 
testing.  
4.5 Critiquing COM-B 
The analyses presented in my thesis make a significant contribution to recasting how COM-B can be 
used in practice by expanding our understandings of the impact of intervention exposure for those 
without pronounced needs while clearly illustrating one of its key weaknesses: the absence of a 
robust concept of need which may lead to improper conception and design of interventions. 
Although COM-B helps illustrate the role of HIVST in meeting the needs of inexperienced testers and 
pro self-testers, the results surrounding opportunistic adopters encourage broader thought on how 
the model can be used.  
Although need is partly captured in motivation (automatic) and opportunity (social), the model does 
not provide sufficient consideration for those who have needs which are based on normative 
practices drawn from the sociocultural tapestry in which they are embedded. The second paper in 
my thesis clearly demonstrates the impact of norms drawn from peers, doctors, public health and 
the voluntary sector in testing narratives (58). This publication underlines the centrality of these in 
decision making processes for MSM. These concepts are further explored in the final paper of my 
thesis which shows that for many MSM (in this analysis pro self-testers and opportunistic adopters) 
norms are one of the primary drivers to test for HIV, even when significant psychosocial barriers 
constrain testing. Need is clearly derived from these norms for a significant number of MSM, a 
phenomena known as biocitizenship (58, 122). 
While COM-B includes some elements of need such as felt need, it is not adequately attentive to 
issues surrounding normative need (need derived from norms) or comparative need (that which is 
derived from interactions with healthcare professionals) (108, 109), which are key drivers to testing 
uptake (58). Indeed, COM-B has a tendency to reduce complex social and psychological process in an 
attempt to control patient variation while prioritising needs identified by healthcare professionals 
(139). This perhaps contributes to the issue identified in paper 5, whereby intervention components 
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have little impact on individuals who take-up interventions due to needs not captured in the model 
which are therefore not addressed in intervention development based on COM-B.  
Although these elements can be retroactively identified and interventions adapted in response, 
using only COM-B in planning interventions can cause these important issues to be overlooked and 
can lead to interventions which are primarily attentive to the priorities of healthcare professionals 
and those implementing the interventions. It also has an important impact on how interventions are 
conceptualised and what their role is assumed to be; it seems that for many MSM with established 
testing routines HIVST may not be primarily useful for identifying prevalent and incident infections 
more rapidly. Rather its utility may lie in its ability to meet normative and comparative need more 
quickly in MSM well served by existing testing interventions. A reliance on COM-B may obscure this 
role by thinking of the intervention as meeting a specified biomedical outcome important to those 
planning and delivering interventions and with all intervention components working towards that, 
rather than outcomes also important to MSM themselves. Using social theory relating to concepts of 
biological citizenships and biomedicalisation of risk early in intervention development has enabled 
some of these issues to be identified and clear, coherent explanations for variations in experience to 
be identified in a way that reliance solely on COM-B would not allow.  
COM-B should therefore be used with a degree of caution, especially in designing interventions 
which respond to highly normative behaviour. In these contexts it may be preferable to draw from a 
range of theories, likely beyond behaviour change models, which contribute to a more in-depth 
understanding of the potential uses of a technology in heterogenous groups. This will enable 
understandings of use to move beyond individualistic concerns and encourage deeper thought about 
natural variation in patient behaviour, especially that which is related to normative and comparative 
need.  
A recasting of COM-B in this way requires something of a paradigm shift for those working in 
implementation science. Disciplines tend to favour tools which come from their own traditions and 
histories. Clearly in certain contexts the constraints of these produce limitations to how knowledge 
can be usefully produced and applied in real world contexts, potentially threatening successful 
implementation. While COM-B has been useful in gaining much of these understandings, without 
further input from social theory the understandings developed in my thesis would have been partial. 
The analysis from formative work has been central in interpretation and demonstrating why COM-B 
on its own would have been insufficient for these purposes.  
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4.6 Strengths and limitations 
My thesis has several strengths alongside some limitations. Much of the first formative, 
implementation and evaluative evidence pertaining to HIVST in the UK is included in this work, as my 
thesis has been embedded within a pioneering programme of research. As such many of the findings 
are novel and have much relevance for policy makers and commissioners more broadly.  
Embedding this thesis within a broader package of work has allowed for a programmatic approach 
not possible in many other projects. The movement from pre-implementation formative work to 
piloting and implementation research to evaluative work has allowed for a broader examination of 
HIVST in a variety of contexts. Further, this has enabled a tracking of emerging understandings of the 
technology, beginning at a relative unknown stage and moving towards normalisation and adoption.  
From a methodological perspective, rejecting the tyranny of the method (116) and disentangling my 
research from any particular paradigm and instead focusing on the method most appropriate for 
each question I sought to answer has given this work the strength of responding very specifically to 
individual challenges which emerged over the research process. This pragmatic approach has likely 
increased the rigour and utility of these findings, while also allowing for an examination of COM-B.  
While my thesis provides a great deal of formative evidence supporting the implementation of 
HIVST, it should be treated with some caution. The research included in the formative papers were 
conducted before HIVST was widely available and it is likely that values and preferences related to 
interventions will have changed as an increasing number of people have been exposed to HIVST. 
These papers should therefore be used as a guide alongside local understandings and the wider 
literature.  
Concerns about capability are a clear theme running through this thesis. It is likely that these will 
shift over time, potentially diminishing as individuals gain more knowledge and skills as 
demonstrated in papers 3 and 4. Countering these is clearly an important priority during early 
implementation but it must be acknowledged that the landscape will change over time and as HIVST 
becomes mainstream.  
4.7 Recommendations for future research 
The self-testing evidence base will inevitably continue to develop from this point. On the basis of this 
body of work I am in a position to make key recommendations for areas of inquiry. Firstly, HIVST 
may have the potential to either exacerbate or reduce testing inequalities based on ethnic identity, 
depending on intervention design. More research is required to inform the development and 
implementation of HIVST programmes that meet the needs of black and minority ethnic MSM, a key 
group in the HIV response (12, 30, 140).  
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Secondly, questions regarding the potential of HIVST to contribute to harm require additional 
inquiry, especially given two adverse events were spontaneously discovered during qualitative 
interviews. The development of this evidence base should be treated as a critical priority in order to 
develop additional supportive interventions which respond to these issues. 
5. Conclusion 
My thesis is an exploration of key formative, implementation and evaluative questions surrounding 
HIVST in England and Wales. This multi-method enquiry provides a substantial evidence base upon 
which commissioning decisions for self-testing can be made. I demonstrate that HIVST adaptations 
can impact on acceptability for sub-groups of MSM depending on their personal circumstances. I 
also provide evidence surrounding the potential context of use, based on narrative understandings 
of self-testing. The feasibility and acceptability of HIVST is explored in a great deal of depth, as is the 
functioning of the SELPHI interventions. Finally, the utility of COM-B is explored in the context of 
HIVST, results which may have direct relevance to other new prevention technologies.  
Clearly, throughout this work, I have demonstrated the significant contribution that HIVST can make 
to the well-being of MSM in England & Wales. Self-testing for HIV serves divergent roles for different 
groups; my most significant contribution to the literature is perhaps the exploration of these and 
demonstrating the ways in which this innovative testing approach can meet MSM’s testing 
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Appendix 3: Focus group discussions topic guide 




Focus Group topic guide  
 
Advance Preparation 
Arrange tables and chairs - prepare refreshments. 
Set up and check the TWO digital recorders.  
Organise focus group materials – hand-outs for ranking exercises.  
Organise focus group materials – HIV-ST kits. 
Notepad, pen, list of attendees, copy of focus group outline for facilitators. 
Arrange chart paper and markers. 
Make sure watch/clock is in sight. 
Distribute consent forms as men arrive – ensure they are signed and collected before start. 
Opening talk 
Introduction of facilitators and Sigma Research 
Rules - Share as much or as little information as you are comfortable with 
Rules – reinforce confidentiality of the group 
Rules - respect for other’s opinions / we want everyone to contribute 
Describe the reason for audio recording and later destruction (3 months hence) 
Encourage participants to talk one at a time for recordings’ sake. 
Group will take about 90 minutes and will finish at [time] at the latest.   
Ask participants to turn off (or at least mute) mobile phones 
Invite queries..  
 
  
Date Focus group number Venue Staff Present 




Ice breaker – 10 minutes 
So, to kick off I’d like us to all introduce ourselves. As you do so, I’m really interested to hear about 
what kind of messages you get about HIV testing from health care organisations or from health 
professionals. Now that could be your GP, from a charity or from advertising campaigns. If you’ve 
noticed that these messages have changed over time I’d be really interested in hearing your 
thoughts on that too.  
Part 1: How HIV-ST fits into health seeking frameworks– 25 minutes 
Now I’d like to talk about HIV self-testing. It is different from what is known as HIV self-sampling. 
With self-sampling you take your own sample and send it to a lab. Self-testing is when you take your 
own sample, process it yourself, and then read your own result. Just to reiterate, it’s a test that you 
get your results very quickly with, and that you are able to do without anyone else present.  
So, let’s brainstorm first about what the key benefits of HIV self-testing are.  
Why might someone want to test themselves for HIV? [Ensure that opportunity and motivation are 
covered, particularly in relation to social and physical opportunity] 
And now the key drawbacks.  
What do you think are the things that might stop someone from testing themselves for HIV? 
[Ensure that barriers in relation to opportunity and motivation are explored] 
Now I’m wondering if there are particular situations that are more or less appropriate for HIV-ST? 
Is there a time when you think someone would be more likely to use this approach?  
Are there other times where a different approach would be better?  
And how do you think people would make these decisions? Are they in any way informed by risk? 
Is there a way that we could support these decision making processes? 
I’m also curious about how individual’s peer groups might influence their decision making. Do you 
think that peers have a big impact on HIV testing decisions? And could they have an influence on 
self-testing decision making processes? 
Com-b Domains: Opportunity – social & physical; Motivation – automatic and reflective.  
Outputs: Discussion notes to be recorded on flipchart and photographed after the FGD.   
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Part 2: intervention specific details – 25 minutes 
 
So now I’d like to talk about what HIV self-testing might look like in practice. This will involve a 
couple of activities, a bit of discussion and then I’ll open up some different self-tests for you to look 
at.  
Firstly, I’m wondering what you think is the most important or effective way to get people interested 
in HIV self-testing.  
What kind of promotion of self-testing would be appropriate?  
Is there anything that would be totally inappropriate?  
Com-b domains: education, persuasion and enablement.  
HIV self-testing kits are currently only available if you pay for them yourselves. I’m curious, with all 
the different HIV testing options available to you, would you be willing to pay for a kit? And how 
much ££?  
Com-b domains: incentivisation 
Does anyone know how much an HIV self-testing kit currently costs? 
 
If these were free to you as part of a clinical trial, how often do you think you would test yourself? 
And when would you test yourself? Every few weeks or months, or between partners? If you had an 
unlimited supply, what would make you test? 
Now I’d like to do some quick exercises where first we chose between two different options, then 
order the importance of these options in relation to each other. HIV self-testing kits can have many 
different features. Some of the differences are around sample type (blood spot or saliva) and length 
of the window period. The packaging can be really different as can the price. Some are easier to use 
than others. Some have videos that show you how to use them, while others rely more on written 
instructions.  
 [Action: Hand out cards with 5x testing features, ask participants to choose between them on the 
following questions and explain their choices. After they have chosen perform a ranking exercise 
putting the categories in order of importance – may not be consensus so keep careful notes]  
What do you think is the most important feature of an HIV self-testing kit?   
Test features:  
Sample type (blood vs. saliva). 
Window period (12 weeks vs. 4 weeks). 
Directions (video vs. written) and ease of use. 
How they are accessed or delivered to you (posted to your address vs. pick-up / physical 
distribution).  
 
Com-B domains: enablement, training 
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Now that we’ve discussed these options, let’s look at some actual kits and I’ll talk you through their 
features. [Action: open up two Biosure and one Ora-quick kit. Explain the features of both of them, 
collect feedback on kits themselves]. 
What are the advantages and disadvantages of both kits?  
Outputs: Photographs of results of ranking activities; discussion notes to be recorded on flipchart and 
photographed after the FGD.  
Part 3: support, positive results and adverse events 10-15 minutes 
What I’d like to talk about now is what kind of support might be useful for people who have tested 
themselves for HIV.  
First off, let’s talk about people who have self-tested HIV negative.  
What do you think their support needs might be?  
What types of issues come up for men who receive a negative HIV test result? 
Now let’s think about the same for those who have a positive result.  
What kind of support do you think they will need? 
What types of issues come up for men who receive a positive HIV test result? 
The other thing that sometimes gets talked about alongside HIV self-testing is what kind of harm 
could come from letting people test themselves for HIV.  
Can you think of any specific difficulties that people are likely to face in using HIV self-tests?  
There are a lot of ways that support could be provided to people who have tested themselves for 
HIV. Three options are online support, support through the telephone (perhaps on a helpline), and 
printed information. What support do you think would be the most useful and why?  




Part 4: HIV-ST verses other testing models – 20-25 minutes 
There are a lot of different ways to test for HIV, and these different ways all have particular 
advantages and disadvantages. Now that we’re coming to the end of the focus group I’d like to do an 
activity comparing some different testing approaches. First I’ll walk you through what they are, and 
I’ll explain what I’d like us to do.   
Quick descriptions 
GUM - One of the most popular ways is to test is in a GUM clinic. Most of the time you can get your 
result right there and then, although sometimes you have to wait a week or two.  
GP – Some people like to test that their GP.  
Community based testing – In the last few years there has been a lot of emphasis on testing for HIV 
in community venues like bars, saunas and in vans.  
Self-sampling – Recently there have been programmes where people are sent a self-sampling kit in 
the post. The person takes their own sample and sends it back to a lab. The lab then processes this 
and contacts the person to give their result (usually by phone).  
Self-testing – self-testing is similar to self-sampling but in this approach people actually process the 
sample themselves and interpret their own results.  
Activity 
I’ve made cards with all of these services on them and am interested in hearing from you what you 
think about key benefits and drawbacks of these approaches, particularly in relation to each other.  
[Following each ranking activity ensure results are discussed]. 
First off, let’s take a really wide view and talk about accessibility. Ranking these in order, which are 
the most and least accessible testing service.  
Moving on, we’re interested in confidentiality. Would you please rank these services in order of 
most to least confidential?  
Another related issue that often gets discussed around HIV testing is fear. Assuming that you had 
decided to go for an HIV test this week, which of these services would make you the most or least 
fearful and why?   
Com-B domains covered: Capability- psychological and physical. Opportunity- physical. 
Outputs: Results of ranking activities to be photographed or recorded verbally.  
That’s great- I think we’ve got a really good idea of these key areas of HIV testing.  
Anything else you want to tell us about HIV self-testing? 





Appendix 4: Focus group discussions sampling frame 
  
Demographic characteristics Minimum Maximum 
Age 18 - 25 years 
26 - 40 years 















Sexual orientation Gay 
Bisexual 
Don’t use a term / other 






Recency of HIV 
testing 
Never tested 
12 months + 








Previous HIV testing 
locations (not 













  8 men 
  8 men 
  15 men 
  8 men 
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Appendix 5: Poster results of formative key informant interviews 
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Appendix 6: Pilot interview topic guide 
1. Introductions  
- Researcher, Sigma, LSHTM 
- This is an interview to hear your thoughts on HIVST. You’ve been invited because of your 
involvement with the Selphi trial, and specifically because you’ve been offered repeat tests. 
I’ll ask you some specific questions about yourself, some questions about your history and 
some questions about your thoughts and experiences of HIVST. Feel free to answer them 
however you see fit. There are no right or wrong answers etc.  
 
2. Ethics 
- We would like to record the interview so we don’t miss any of what you say.  
- Explain how we will use and protect the data 
- Do you have any questions? 
-  Are you happy to proceed? 
 
3. HIV testing history 
- When was your first HIV test? 
- Can you remember what prompted you to seek testing the first time you went? 
- What was the experience like? Where did you go? How did you choose to test that way?  
- What kind of support were you provided with?  
(Prompt: Was this what you wanted? Can you think of anything else that would have been 
helpful for you in that situation?)  
 
4. HIV testing patterns 
- How often do you test for HIV typically? Do you always get an STI screen when you test for 
HIV? 
(Prompt: Do you have a usual clinic that you go to? How did you choose that clinic?) 
- Can you think of how you have formed your testing patterns? 
- What has influenced your thoughts on testing? 
 
5. Seeking HIVST 
- When did you first hear about HIVST?  
- What were your initial thoughts?  
- How did you hear about the SELFI study? What make you decide to take part? 
- How did you find the process of signing up? Was there anything difficult?  
- Did delivery of the kits go well?  
 
6. Experience of HIVST 
- Thinking back to when you took your first self-test, what was going through your mind?  
(Prompt: did you think there was a possibility of a positive result?) 
- Did you decide to take the test by yourself or was there someone with you? 
- What were your impressions of the kit? Did you watch any of the videos online? 
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(Prompt: what did you think of the instructions? Did the kit look easy to use? 
- What was your experience of using the test kit like?  
(Prompt: Do you think you made any mistakes?) 
- Describe your experience of reading the result? 
- Did you trust the result that your test gave you? 
(Prompt: Did you seek support from anywhere?) 
- Have the emails prompting you to think about testing again been helpful to you?  
- How have these experiences changed as you’ve used more kits over time? Are your emotional 




Appendix 7: Updated topic guide 
Topic guide one-to-one interviews 
1. Introductions  
- Researcher, Sigma, LSHTM 
- This is an interview to hear your thoughts on HIVST. You’ve been invited because of your 
involvement with the SELPHI study. I’ll ask you some specific questions about yourself, and 
some questions about your history. Feel free to answer them however you see fit. There are 
no right or wrong answers etc.  
 
2. Ethics 
- We would like to record the interview so we don’t miss any of what you say.  
- Explain how we will use and protect the data 
- Do you have any questions? 
-  Are you happy to proceed? 
 
3. HIV testing history  
- Have you tested for HIV before?  
If no  
- Have you considered HIV testing before? 
- What has stopped you? 
- Have you ever tested for STIs?  
- Have you ever considered testing but not gone? 
- Can you tell me about the last time you heard about HIV testing? From whom? Where? What 
was the message?  
- What did it make you think? Was this different to other messages/images about HIV testing 
that you’ve seen in the past? How?  
If yes 
- Can you tell me about the first time you tested for HIV? 
- Can you remember what prompted you to seek testing the first time you went? 
- What was the experience like? Where did you go? How did you choose to test that way?  
- What kind of support were you provided with? Was this what you wanted?  
- Can you think of anything else that would have been helpful for you in that situation? 
- How about the last time you tested before SELPHI? Can you tell me a bit more about that?  
- Where did you go? How did you make that decision? What kind of support did you get? 
 
4. HIV testing patterns (If previously tested) 
- What is usually your motivation to test? Do you have conversations about HIV testing with 
your friends? Are you ever prompted to test by discussions you have with others? Do your 
friends support each other around HIV testing? 
- How often do you test for HIV typically? Do you always get an STI screen when you test? 
(prompt: Do you have a testing routine? Do you think this is common with your friends? Do 
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doctors ever prompt you to test?) 
- What challenges have you faced when taking a test of thinking about testing? Are there things 
that have stopped you from testing? Or that make testing more difficult?  
- Has there been anything that has made testing easier for you?  
- Can you think of how you have formed your testing patterns? 
- What or who has influenced your thoughts on testing? 
- The last time you had a risk, did you consider going for an HIV test? Describe your decision 
making process around that? Where did you go? What role does risk play for you generally 
in testing for HIV?  
- (if not answered) what kind of risk would prompt you to look for an HIV test?  
- Has there ever been a time you tested when you were genuinely concerned you may be HIV 
positive? What made you think that? How did you test and what led you to choose that 
method? Is that the same thing you would do now? 
 
5. Initial engagement with HIVST & SELPHI 
- When did you first hear about HIVST?  
- What were your initial thoughts?  
- How did you hear about the SELPHI study? What make you decide to take part? 
- Do you remember the advert for the study that you saw? Anything stick in your mind from 
that?  
- [Show study advert] Here’s the advert you were recruited from. What do you think about it? 
Is there anything you find appealing or not about it? Was it motivational in any way? 
- How did you find the process of signing up? Was there anything difficult? Anything that you 
didn’t understand? 
- [Show registration and enrolment surveys] Here are the surveys that you filled out at the 
time. What jumps out in your mind about these?  
- Do you have any thoughts on why I might be curious about what these questions made you 
think?  
- Were there any of these questions unclear when you completed the surveys? Any that you 
didn’t feel comfortable answering?  
- How long did it take for your kit to arrive? 
 
6. Experience of HIVST & trial infrastructure 
- [Show kit with accompanying sleeve] This is the same version of the test we sent you. Can 
you remember what your first impressions of it were? (Make sure sleeve and kit itself are 
covered in conversation) 
- Thinking back to when you first took the self-test, what was going through your mind?  Tell me 
everything you can about the first time you used HIVST (Prompt: Where were you? did you 
think there was a possibility of a positive result?).  
- Did you decide to take the test by yourself or was there someone with you? 
- Did you read the instructions? How many times?  
(Prompt: if not answered: What did you make of them? Did you watch any of the videos 
online? Did the kit look easy to use?) 
- How was your overall experience of using the test kit?  
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(Prompt: Do you think you made any mistakes? Was it difficult to use the lancet?) 
- Describe your experience of reading the result. 
- What did you do immediately after you took the test?  
- How did you feel after using HIVST? Did you trust the result that your test gave you? 
- Did you seek support from anywhere?  
- Have you talked to anyone about HIVST? Did you tell anyone you had taken a self-test? 
What did you tell them about the experience? What do you think they thought about it? 
- Do you remember receiving a follow-up survey about two weeks after you took the test? What 
were your impressions?  
-  [Show copy of email and two week survey] This is what it would have looked like. Can you 
think about how you reacted to this? (prompt: did you recognise this as a form of support?) 
- [Show copy of email and three month survey] Do you remember receiving this survey? What 
was your initial reaction to the email? Did you fill the survey out?  
 
7. Experiences of randomisation B (if randomised to RT) 
- So you were randomised to receive repeat testing at your three month point.  
- How have you felt about the offer of repeat testing? Has it been useful? How many tests have 
you had through SELPHI now? Have you used all the tests that have been offered? (if not 
used) what has influenced you to not take a test? 
- Are you also accessing other testing options?  
- [Show copy of email and three month survey] Have these emails been useful in prompting 
you for more testing?  
- Have there been changes to the way you think about testing through this process? 
 
8. After HIVST 
- What are your thoughts on using an oral fluid test rather than blood? 
- What do you understand by the term ‘window period’? 
- Have you thought about having an STI screen as well?  
- On reflection, is there any additional support you would want with an HIVST?   
- Do you think your behaviour will change in any way following the experience of using HIVST? 
- Would you use HIVST again if it was available to you? Would you use it alongside other 
services or instead? 
- Is there someone or a group of people you think HIVST is particularly good for? Anyone that it 
is not suitable for?  
 
 
